Cell-type-specific	O
regulation	O
of	O
the	O
human	B-DNA
tumor	I-DNA
necrosis	I-DNA
factor	I-DNA
alpha	I-DNA
gene	I-DNA
in	O
B	B-cell_type
cells	I-cell_type
and	O
T	B-cell_type
cells	I-cell_type
by	O
NFATp	B-protein
and	O
ATF-2/JUN	B-protein
.	O

The	O
human	B-DNA
tumor	I-DNA
necrosis	I-DNA
factor	I-DNA
alpha	I-DNA
(	I-DNA
TNF-alpha	I-DNA
)	I-DNA
gene	I-DNA
is	O
one	O
of	O
the	O
earliest	O
genes	O
transcribed	O
after	O
the	O
stimulation	O
of	O
a	O
B	B-cell_type
cell	I-cell_type
through	O
its	O
antigen	B-protein
receptor	I-protein
or	O
via	O
the	O
CD-40	O
pathway	O
.	O

In	O
both	O
cases	O
,	O
induction	O
of	O
TNF-alpha	B-DNA
gene	I-DNA
transcription	O
can	O
be	O
blocked	O
by	O
the	O
immunosuppressants	O
cyclosporin	O
A	O
and	O
FK506	O
,	O
which	O
suggested	O
a	O
role	O
for	O
the	O
NFAT	B-protein
family	I-protein
of	O
proteins	O
in	O
the	O
regulation	O
of	O
the	O
gene	O
in	O
B	B-cell_type
cells	I-cell_type
.	O

Furthermore	O
,	O
in	O
T	B-cell_type
cells	I-cell_type
,	O
two	O
molecules	O
of	O
NFATp	B-protein
bind	O
to	O
the	O
TNF-alpha	B-DNA
promoter	I-DNA
element	I-DNA
kappa	I-DNA
3	I-DNA
in	O
association	O
with	O
ATF-2	B-protein
and	O
Jun	B-protein
proteins	I-protein
bound	O
to	O
an	O
immediately	O
adjacent	O
cyclic	B-DNA
AMP	I-DNA
response	I-DNA
element	I-DNA
(	I-DNA
CRE	I-DNA
)	I-DNA
site	I-DNA
.	O

Here	O
,	O
using	O
the	O
murine	B-cell_line
B-cell	I-cell_line
lymphoma	I-cell_line
cell	I-cell_line
line	I-cell_line
A20	B-cell_line
,	O
we	O
show	O
that	O
the	O
TNF-alpha	B-DNA
gene	I-DNA
is	O
regulated	O
in	O
a	O
cell-type-specific	O
manner	O
.	O

In	O
A20	B-cell_line
B	I-cell_line
cells	I-cell_line
,	O
the	O
TNF-alpha	B-DNA
gene	I-DNA
is	O
not	O
regulated	O
by	O
NFATp	B-protein
bound	O
to	O
the	O
kappa	B-DNA
3	I-DNA
element	I-DNA
.	O

Instead	O
,	O
ATF-2	B-protein
and	O
Jun	B-protein
proteins	I-protein
bind	O
to	O
the	O
composite	B-DNA
kappa	I-DNA
3/CRE	I-DNA
site	I-DNA
and	O
NFATp	B-protein
binds	O
to	O
a	O
newly	O
identified	O
second	O
NFAT	B-DNA
site	I-DNA
centered	O
at	O
-76	B-DNA
nucleotides	I-DNA
relative	O
to	O
the	O
TNF-alpha	B-DNA
transcription	I-DNA
start	I-DNA
site	I-DNA
.	O

This	O
new	O
site	O
plays	O
a	O
critical	O
role	O
in	O
the	O
calcium-mediated	O
,	O
cyclosporin	O
A-sensitive	O
induction	O
of	O
TNF-alpha	B-protein
in	O
both	O
A20	B-cell_line
B	I-cell_line
cells	I-cell_line
and	O
Ar-5	B-cell_line
cells	I-cell_line
.	O

Consistent	O
with	O
these	O
results	O
,	O
quantitative	O
DNase	B-protein
footprinting	O
of	O
the	O
TNF-alpha	B-DNA
promoter	I-DNA
using	O
increasing	O
amounts	O
of	O
recombinant	O
NFATp	B-protein
demonstrated	O
that	O
the	O
-76	B-DNA
site	I-DNA
binds	O
to	O
NFATp	B-protein
with	O
a	O
higher	O
affinity	O
than	O
the	O
kappa	B-DNA
3	I-DNA
site	I-DNA
.	O

Two	O
other	O
previously	O
unrecognized	O
NFATp-binding	B-DNA
sites	I-DNA
in	O
the	O
proximal	O
TNF-alpha	B-DNA
promoter	I-DNA
were	O
also	O
identified	O
by	O
this	O
analysis	O
.	O

Thus	O
,	O
through	O
the	O
differential	O
use	O
of	O
the	O
same	O
promoter	B-DNA
element	I-DNA
,	O
the	O
composite	B-DNA
kappa	I-DNA
3/CRE	I-DNA
site	I-DNA
,	O
the	O
TNF-alpha	B-DNA
gene	I-DNA
is	O
regulated	O
in	O
a	O
cell-type-specific	O
manner	O
in	O
response	O
to	O
the	O
same	O
extracellular	O
signal	O
.	O

MoLECULAR	NULL
AND	NULL
CELLULAR	NULL
BroLoGY	NULL
,	NULL
Oct.	NULL
1996	NULL
,	NULL
p.	NULL
5232-5244	NULL
0270-7306/96/	NULL
$	NULL
04.00+0	NULL
Copyright	NULL
©	NULL
1996	NULL
,	NULL
American	NULL
Society	NULL
for	NULL
Microbiology	NULL
Vol	NULL
.	NULL

16	NULL
,	NULL
No	NULL
.	NULL

10	NULL
Cell-Type-Specific	NULL
Regulation	NULL
of	NULL
the	NULL
Human	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
Alpha	NULL
Gene	NULL
in	NULL
B	NULL
Cells	NULL
and	NULL
T	NULL
Cells	NULL
by	NULL
NFATp	NULL
and	NULL
ATF-2/JUN	NULL
EUNICE	NULL
Y.	NULL
TSAL	NULL
,	NULL
*	NULL
JUNMING	NULL
YIE	NULL
,	NULL
DIMITRIS	NULL
THANOS	NULL
,	NULL
``	NULL
anp	NULL
ANNE	NULL
E.	NULL
GOLDFELD'*	NULL
Infectious	NULL
Disease	NULL
Laboratory	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
and	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
Boston	NULL
,	NULL
Massachusetts	NULL
02115	NULL
,	NULL
``	NULL
and	NULL
Department	NULL
of	NULL
Biochemistry	NULL
and	NULL
Biophysics	NULL
,	NULL
Columbia	NULL
University	NULL
,	NULL
New	NULL
York	NULL
,	NULL
New	NULL
York	NULL
10032	NULL
Received	NULL
23	NULL
May	NULL
1996/Returned	NULL
for	NULL
modification	NULL
3	NULL
July	NULL
1996/Accepted	NULL
11	NULL
July	NULL
1996	NULL
The	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-	NULL
«	NULL
@	NULL
)	NULL
gene	NULL
is	NULL
one	NULL
of	NULL
the	NULL
earliest	NULL
genes	NULL
transcribed	NULL
after	NULL
the	NULL
stimulation	NULL
of	NULL
a	NULL
B	NULL
cell	NULL
through	NULL
its	NULL
antigen	NULL
receptor	NULL
or	NULL
via	NULL
the	NULL
CD40	NULL
pathway	NULL
.	NULL

In	NULL
both	NULL
cases	NULL
,	NULL
induction	NULL
of	NULL
TNF-	NULL
«	NULL
gene	NULL
transcription	NULL
can	NULL
be	NULL
blocked	NULL
by	NULL
the	NULL
immunosuppressants	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
,	NULL
which	NULL
suggested	NULL
a	NULL
role	NULL
for	NULL
the	NULL
NFAT	NULL
family	NULL
of	NULL
proteins	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
two	NULL
molecules	NULL
of	NULL
NFATp	NULL
bind	NULL
to	NULL
the	NULL
TNF-a	NULL
promoter	NULL
element	NULL
3	NULL
in	NULL
association	NULL
with	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
bound	NULL
to	NULL
an	NULL
immediately	NULL
adjacent	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
site	NULL
.	NULL

Here	NULL
,	NULL
using	NULL
the	NULL
murine	NULL
B-cell	NULL
lymphoma	NULL
cell	NULL
line	NULL
A20	NULL
,	NULL
we	NULL
show	NULL
that	NULL
the	NULL
TNF-a	NULL
«	NULL
gene	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
cell-type-specific	NULL
manner	NULL
.	NULL

In	NULL
A20	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
is	NULL
not	NULL
regulated	NULL
by	NULL
NFATp	NULL
bound	NULL
to	NULL
the	NULL
3	NULL
element	NULL
.	NULL

Instead	NULL
,	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
bind	NULL
to	NULL
the	NULL
composite	NULL
©3/CRE	NULL
site	NULL
and	NULL
NFAT	NULL
p	NULL
binds	NULL
to	NULL
a	NULL
newly	NULL
identified	NULL
second	NULL
NFAT	NULL
site	NULL
centered	NULL
at	NULL
-76	NULL
nucleotides	NULL
relative	NULL
to	NULL
the	NULL
TNF-a	NULL
«	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

This	NULL
new	NULL
site	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
calcium-mediated	NULL
,	NULL
cyclosporin	NULL
A-sensitive	NULL
induction	NULL
of	NULL
TNF-a	NULL
in	NULL
both	NULL
A20	NULL
B	NULL
cells	NULL
and	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

Consistent	NULL
with	NULL
these	NULL
results	NULL
,	NULL
quantitative	NULL
DNase	NULL
footprinting	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
using	NULL
increasing	NULL
amounts	NULL
of	NULL
recombinant	NULL
NFATp	NULL
demonstrated	NULL
that	NULL
the	NULL
-76	NULL
site	NULL
binds	NULL
to	NULL
NFATp	NULL
with	NULL
a	NULL
higher	NULL
affinity	NULL
than	NULL
the	NULL
x3	NULL
site	NULL
.	NULL

Two	NULL
other	NULL
previously	NULL
unrecognized	NULL
NFAT	NULL
sites	NULL
in	NULL
the	NULL
proximal	NULL
TNF-a	NULL
«	NULL
&	NULL
promoter	NULL
were	NULL
also	NULL
identified	NULL
by	NULL
this	NULL
analysis	NULL
.	NULL

Thus	NULL
,	NULL
through	NULL
the	NULL
differential	NULL
use	NULL
of	NULL
the	NULL
same	NULL
promoter	NULL
element	NULL
,	NULL
the	NULL
composite	NULL
site	NULL
,	NULL
the	NULL
TNF-	NULL
«	NULL
@	NULL
gene	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
cell-type-specific	NULL
manner	NULL
in	NULL
response	NULL
to	NULL
the	NULL
same	NULL
extracellular	NULL
signal	NULL
.	NULL

The	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
(	NULL
TNF-	NULL
«	NULL
)	NULL
gene	NULL
is	NULL
expressed	NULL
in	NULL
multiple	NULL
cell	NULL
types	NULL
and	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
a	NULL
variety	NULL
of	NULL
stimuli	NULL
in	NULL
a	NULL
highly	NULL
specific	NULL
and	NULL
temporal	NULL
manner	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
5	NULL
)	NULL
.	NULL

Studies	NULL
of	NULL
TNF-	NULL
«	NULL
gene	NULL
regulation	NULL
have	NULL
served	NULL
as	NULL
a	NULL
model	NULL
system	NULL
for	NULL
the	NULL
analysis	NULL
of	NULL
mechanisms	NULL
involved	NULL
in	NULL
complex	NULL
patterns	NULL
of	NULL
cell-type-	NULL
and	NULL
inducer-type-specific	NULL
gene	NULL
transcription	NULL
(	NULL
4	NULL
,	NULL
6-8	NULL
,	NULL
14	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Several	NULL
cis-acting	NULL
elements	NULL
and	NULL
protein	NULL
factors	NULL
involved	NULL
in	NULL
the	NULL
gene	NULL
's	NULL
expression	NULL
have	NULL
previously	NULL
been	NULL
identified	NULL
.	NULL

The	NULL
x3	NULL
site	NULL
,	NULL
for	NULL
example	NULL
,	NULL
located	NULL
at	NULL
-97	NULL
to	NULL
-88	NULL
nucleotides	NULL
(	NULL
nt	NULL
)	NULL
relative	NULL
to	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
transcription	NULL
start	NULL
site	NULL
(	NULL
6	NULL
)	NULL
,	NULL
binds	NULL
two	NULL
molecules	NULL
of	NULL
NFATp	NULL
(	NULL
8	NULL
)	NULL
,	NULL
and	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
bind	NULL
to	NULL
a	NULL
cyclic	NULL
AMP	NULL
response	NULL
element	NULL
(	NULL
CRE	NULL
)	NULL
immediately	NULL
upstream	NULL
of	NULL
3	NULL
(	NULL
8	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Consensus	NULL
sequences	NULL
for	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
and	NULL
SP-1	NULL
sites	NULL
have	NULL
also	NULL
been	NULL
identified	NULL
(	NULL
4	NULL
,	NULL
8	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Previous	NULL
studies	NULL
of	NULL
TNF-	NULL
«	NULL
gene	NULL
regulation	NULL
in	NULL
the	NULL
murine	NULL
T-cell	NULL
clone	NULL
Ar-5	NULL
stimulated	NULL
through	NULL
the	NULL
T-cell	NULL
receptor	NULL
or	NULL
by	NULL
calcium	NULL
ionophore	NULL
demonstrated	NULL
that	NULL
the	NULL
x3	NULL
site	NULL
is	NULL
both	NULL
necessary	NULL
and	NULL
sufficient	NULL
to	NULL
confer	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
-sensitive	NULL
inducibility	NULL
on	NULL
a	NULL
minimal	NULL
TNF-	NULL
«	NULL
promoter	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
ATF-2-Jun	NULL
heterodimers	NULL
bind	NULL
to	NULL
the	NULL
adjacent	NULL
CRE	NULL
site	NULL
and	NULL
functionally	NULL
cooperate	NULL
with	NULL
NFATp	NULL
to	NULL
mediate	NULL
the	NULL
CsA-sensitive	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
.	NULL

TNF-a	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
B-cell	NULL
biology	NULL
and	NULL
functions	NULL
as	NULL
an	NULL
autocrine	NULL
growth	NULL
factor	NULL
for	NULL
highly	NULL
purified	NULL
human	NULL
splenic	NULL
B	NULL
cells	NULL
activated	NULL
via	NULL
surface	NULL
immunoglobulin	NULL
(	NULL
Ig	NULL
)	NULL
or	NULL
CD40	NULL
(	NULL
1	NULL
)	NULL
.	NULL

The	NULL
NFAT	NULL
family	NULL
of	NULL
proteins	NULL
have	NULL
also	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
*	NULL
Corresponding	NULL
author	NULL
.	NULL

Mailing	NULL
address	NULL
:	NULL
Infectious	NULL
Discase	NULL
Laboratory	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Dana-Farber	NULL
Cancer	NULL
Institute	NULL
and	NULL
Harvard	NULL
Medical	NULL
School	NULL
,	NULL
44	NULL
Binney	NULL
St.	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
02115	NULL
.	NULL

Electronic	NULL
mail	NULL
address	NULL
:	NULL
anne_goldfeld	NULL
@	NULL
macmailgw.dfci.harvard.edu	NULL
.	NULL

5232	NULL
regulation	NULL
of	NULL
TNF-	NULL
«	NULL
in	NULL
B	NULL
cells	NULL
(	NULL
1	NULL
,	NULL
7	NULL
,	NULL
10	NULL
)	NULL
.	NULL

First	NULL
,	NULL
the	NULL
rapid	NULL
induction	NULL
of	NULL
TNF-	NULL
«	NULL
gene	NULL
expression	NULL
in	NULL
highly	NULL
purified	NULL
human	NULL
splenic	NULL
B	NULL
cells	NULL
induced	NULL
by	NULL
antibodies	NULL
to	NULL
the	NULL
immunoglobulin	NULL
receptor	NULL
(	NULL
anti-Ig	NULL
)	NULL
or	NULL
to	NULL
CD40	NULL
is	NULL
blocked	NULL
by	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
CsA	NULL
and	NULL
FK506	NULL
and	NULL
does	NULL
not	NULL
require	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
(	NULL
1	NULL
,	NULL
7	NULL
)	NULL
.	NULL

Second	NULL
,	NULL
calcineurin	NULL
phosphatase	NULL
activity	NULL
is	NULL
required	NULL
for	NULL
TNF-a	NULL
induction	NULL
by	NULL
anti-Ig	NULL
,	NULL
since	NULL
a	NULL
panel	NULL
of	NULL
calcineurin	NULL
inhibitors	NULL
blocks	NULL
transcription	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
(	NULL
10	NULL
)	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
panel	NULL
of	NULL
calcineurin	NULL
inhibitors	NULL
significantly	NULL
blocked	NULL
TNF-a	NULL
«	NULL
-mediated	NULL
B-cell	NULL
proliferation	NULL
induced	NULL
by	NULL
either	NULL
anti-Ig	NULL
or	NULL
anti-€CD40	NULL
(	NULL
1	NULL
)	NULL
.	NULL

NFATp	NULL
is	NULL
a	NULL
member	NULL
of	NULL
a	NULL
growing	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
includes	NULL
NFATc	NULL
,	NULL
NFAT3	NULL
,	NULL
and	NULL
NFAT4	NULL
(	NULL
11	NULL
,	NULL
16	NULL
,	NULL
19	NULL
,	NULL
22	NULL
)	NULL
.	NULL

Outside	NULL
of	NULL
their	NULL
DNA-binding	NULL
domains	NULL
,	NULL
which	NULL
are	NULL
distantly	NULL
related	NULL
to	NULL
Rel	NULL
domains	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
proteins	NULL
,	NULL
the	NULL
NFAT	NULL
proteins	NULL
show	NULL
minimal	NULL
sequence	NULL
similarity	NULL
and	NULL
have	NULL
different	NULL
patterns	NULL
of	NULL
tissue	NULL
expression	NULL
(	NULL
11	NULL
)	NULL
.	NULL

Originally	NULL
identified	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
hence	NULL
the	NULL
name	NULL
NFAT	NULL
[	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
]	NULL
)	NULL
,	NULL
NFAT	NULL
proteins	NULL
typically	NULL
cooperatively	NULL
bind	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
family	NULL
members	NULL
to	NULL
pyrimidine-rich	NULL
binding	NULL
motifs	NULL
in	NULL
several	NULL
cytokine	NULL
promoters	NULL
(	NULL
19	NULL
,	NULL
22	NULL
,	NULL
25	NULL
,	NULL
26	NULL
;	NULL
reviewed	NULL
in	NULL
references	NULL
13	NULL
and	NULL
23	NULL
)	NULL
.	NULL

Other	NULL
studies	NULL
have	NULL
detected	NULL
the	NULL
presence	NULL
of	NULL
NFAT	NULL
family	NULL
members	NULL
in	NULL
extracts	NULL
prepared	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
murine	NULL
and	NULL
human	NULL
B-cell	NULL
lines	NULL
(	NULL
30-32	NULL
)	NULL
.	NULL

In	NULL
one	NULL
study	NULL
,	NULL
multimers	NULL
of	NULL
the	NULL
NFAT	NULL
-binding	NULL
site	NULL
from	NULL
the	NULL
murine	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
gene	NULL
cloned	NULL
upstream	NULL
of	NULL
a	NULL
minimal	NULL
c-fos	NULL
gene	NULL
promoter	NULL
were	NULL
shown	NULL
to	NULL
be	NULL
induced	NULL
by	NULL
anti-Ig	NULL
in	NULL
murine	NULL
Bal-17	NULL
B	NULL
cells	NULL
(	NULL
31	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
role	NULL
of	NULL
NFATp	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
a	NULL
naturally	NULL
expressed	NULL
gene	NULL
in	NULL
B	NULL
cells	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
demon-strated	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
the	NULL
role	NULL
of	NULL
NFATp	NULL
in	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

Con	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
trary	NULL
to	NULL
our	NULL
expectations	NULL
,	NULL
we	NULL
found	NULL
that	NULL
a	NULL
novel	NULL
NFAT	NULL
-binding	NULL
site	NULL
centered	NULL
at	NULL
-76	NULL
nt	NULL
relative	NULL
to	NULL
the	NULL
TNF-	NULL
«	NULL
mRNA	NULL
cap	NULL
site	NULL
is	NULL
critical	NULL
for	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
our	NULL
findings	NULL
for	NULL
Ar-5	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
TNF-a	NULL
NFATp-binding	NULL
site	NULL
x3	NULL
is	NULL
not	NULL
sufficient	NULL
or	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
.	NULL

Quantitative	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
revealed	NULL
that	NULL
the	NULL
newly	NULL
identified	NULL
site	NULL
is	NULL
a	NULL
higher-affinity	NULL
NFATp-binding	NULL
site	NULL
than	NULL
is	NULL
x3	NULL
and	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
x3	NULL
,	NULL
plays	NULL
an	NULL
important	NULL
functional	NULL
role	NULL
in	NULL
the	NULL
CsA-sensitive	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
analysis	NULL
revealed	NULL
a	NULL
total	NULL
of	NULL
three	NULL
previously	NULL
unrecognized	NULL
NFAT	NULL
-binding	NULL
sites	NULL
in	NULL
addition	NULL
to	NULL
x3	NULL
.	NULL

Similar	NULL
to	NULL
our	NULL
findings	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
CRE	NULL
immediately	NULL
upstream	NULL
of	NULL
x3	NULL
associates	NULL
with	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
and	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
cell-type-specific	NULL
regulation	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
is	NULL
achieved	NULL
through	NULL
the	NULL
differential	NULL
interaction	NULL
of	NULL
NFATp	NULL
with	NULL
the	NULL
composite	NULL
CRE	NULL
site	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
and	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Cell	NULL
culture	NULL
,	NULL
activation	NULL
,	NULL
and	NULL
transfection	NULL
.	NULL

The	NULL
murine	NULL
lymphoma	NULL
line	NULL
A20	NULL
was	NULL
grown	NULL
in	NULL
Dulbecco	NULL
modified	NULL
Eagle	NULL
medium	NULL
supplemented	NULL
with	NULL
12	NULL
%	NULL
fetal	NULL
bovine	NULL
serum	NULL
,	NULL
12	NULL
mM	NULL
N-2-hydroxyethylpiperazine-V'-2-ethanesulfonic	NULL
acid	NULL
(	NULL
HEPES	NULL
)	NULL
,	NULL
2	NULL
mM	NULL
glutamine	NULL
,	NULL
50	NULL
M	NULL
B-mercaptocthanol	NULL
,	NULL
60	NULL
U	NULL
of	NULL
penicillin	NULL
per	NULL
ml	NULL
,	NULL
and	NULL
60	NULL
ug	NULL
of	NULL
streptomycin	NULL
per	NULL
ml	NULL
.	NULL

For	NULL
nuclear	NULL
extract	NULL
preparation	NULL
and	NULL
RNA	NULL
analysis	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
1	NULL
uM	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
(	NULL
Sandoz	NULL
)	NULL
for	NULL
10	NULL
min	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
phorbol	NULL
myris-tate	NULL
acetate	NULL
(	NULL
PMA	NULL
;	NULL
200	NULL
nM	NULL
)	NULL
and/or	NULL
ionomycin	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
.	NULL

Transfections	NULL
were	NULL
performed	NULL
by	NULL
using	NULL
DEAE-dextran	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Twenty-four	NULL
hours	NULL
after	NULL
transfection	NULL
,	NULL
cells	NULL
were	NULL
activated	NULL
with	NULL
PMA	NULL
(	NULL
200	NULL
nM	NULL
)	NULL
plus	NULL
ionomycin	NULL
(	NULL
1	NULL
wM	NULL
)	NULL
(	NULL
P+1	NULL
)	NULL
and	NULL
harvested	NULL
approximately	NULL
18	NULL
h	NULL
later	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
cells	NULL
were	NULL
treated	NULL
for	NULL
10	NULL
min	NULL
with	NULL
1	NULL
uM	NULL
CsA	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
PMA	NULL
or	NULL
iono-mycin	NULL
.	NULL

Chloramphenicol	NULL
acetyltransferase	NULL
(	NULL
CAT	NULL
)	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
14	NULL
)	NULL
.	NULL

Quantification	NULL
of	NULL
the	NULL
conversion	NULL
of	NULL
[	NULL
**CJchloramphenicol	NULL
to	NULL
its	NULL
acetylated	NULL
forms	NULL
was	NULL
obtained	NULL
by	NULL
using	NULL
a	NULL
Betagen	NULL
(	NULL
Waltham	NULL
,	NULL
Mass	NULL
.	NULL
)	NULL

Betascope	NULL
.	NULL

RNA	NULL
analysis	NULL
.	NULL

RNA	NULL
was	NULL
prepared	NULL
from	NULL
A20	NULL
cells	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
6	NULL
)	NULL
.	NULL

``	NULL
P-labeled	NULL
RNA	NULL
probes	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
from	NULL
SP6	NULL
y-actin	NULL
and	NULL
a	NULL
murine	NULL
TNF-	NULL
«	NULL
probe	NULL
,	NULL
and	NULL
RNase	NULL
protection	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
6	NULL
)	NULL
.	NULL

Plasmids	NULL
.	NULL

The	NULL
-200	NULL
TNF-	NULL
«	NULL
CAT	NULL
,	NULL
5	NULL
'M	NULL
,	NULL
MM	NULL
,	NULL
3	NULL
'M	NULL
,	NULL
3'FL	NULL
,	NULL
SP-1	NULL
,	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
C1	NULL
,	NULL
C2	NULL
,	NULL
C3	NULL
,	NULL
and	NULL
(	NULL
«	NULL
3	NULL
)	NULL
5-61	NULL
TNF-a/CAT	NULL
constructs	NULL
have	NULL
all	NULL
previously	NULL
been	NULL
described	NULL
(	NULL
29	NULL
)	NULL
.	NULL

To	NULL
construct	NULL
the	NULL
TNF-	NULL
«	NULL
promoter	NULL
mutants	NULL
extending	NULL
to	NULL
the	NULL
TATA	NULL
box	NULL
,	NULL
site-directed	NULL
mutagenesis	NULL
was	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
31	NULL
)	NULL
,	NULL
using	NULL
a	NULL
Mutagene	NULL
M13	NULL
in	NULL
vitro	NULL
mutagenesis	NULL
kit	NULL
(	NULL
Bio-Rad	NULL
Laboratories	NULL
,	NULL
Richmond	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

Dideoxy	NULL
sequencing	NULL
was	NULL
used	NULL
to	NULL
confirm	NULL
all	NULL
of	NULL
the	NULL
mutations	NULL
.	NULL

Preparation	NULL
of	NULL
Nuclear	NULL
Extracts	NULL
and	NULL
EMSAs	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
18	NULL
)	NULL
,	NULL
and	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
EMSAs	NULL
)	NULL
were	NULL
performed	NULL
with	NULL
approximately	NULL
5	NULL
g	NULL
of	NULL
protein	NULL
in	NULL
a	NULL
total	NULL
volume	NULL
of	NULL
15	NULL
pl	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Unbound	NULL
oligonucleotide	NULL
and	NULL
protein-oligonucleotide	NULL
complexes	NULL
were	NULL
separated	NULL
by	NULL
electrophoresis	NULL
at	NULL
4°C	NULL
on	NULL
Tris-borate-EDTA-4	NULL
%	NULL
acrylamide	NULL
gels	NULL
as	NULL
described	NULL
earlier	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Antibody	NULL
competition	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
31	NULL
)	NULL
,	NULL
using	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
anti-ATF-2	NULL
antibody	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
Tom	NULL
Maniatis	NULL
[	NULL
3	NULL
]	NULL
)	NULL
or	NULL
a	NULL
rabbit	NULL
polyclonal	NULL
anti-NFATp	NULL
antibody	NULL
specific	NULL
for	NULL
NFATp	NULL
(	NULL
anti-67.1	NULL
;	NULL
a	NULL
gift	NULL
from	NULL
Anjana	NULL
Rao	NULL
[	NULL
23	NULL
]	NULL
)	NULL
.	NULL

Antibodies	NULL
to	NULL
Jun	NULL
family	NULL
proteins	NULL
were	NULL
obtained	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
Cruz	NULL
,	NULL
Calif.	NULL
)	NULL
.	NULL

The	NULL
synthetic	NULL
oligonucleotides	NULL
used	NULL
in	NULL
the	NULL
gel	NULL
shift	NULL
assays	NULL
were	NULL
(	NULL
5'-GATCCGAGCTCATGGGTTTCTCCACA-3	NULL
``	NULL
)	NULL
,	NULL
«	NULL
3	NULL
(	NULL
L	NULL
)	NULL
(	NULL
§-GATCCTTCCTCC	NULL
AGATGAGCTCATGGGTTITCTCCACCAAGGAA-7	NULL
``	NULL
)	NULL
,	NULL
C3	NULL
(	NULL
5-GATCCTTC	NULL
CTCCGTCAGAGCTCATGGGTITTCTCCACCAAGGAA-3	NULL
``	NULL
)	NULL
,	NULL
C2	NULL
(	NULL
5-GATC	NULL
CTTCCTCCAGATTGAATCATGGGTITCTCCACCAAGGAA-3	NULL
'	NULL
)	NULL
,	NULL
C1	NULL
(	NULL
5'-G	NULL
ATCCTTCCTCCAGATGAGCAGCTGGGTTTCTCCACCAAGGAA-4	NULL
'	NULL
)	NULL
,	NULL
5	NULL
``	NULL
(	NULL
5'-GATCCTTCCTCCAGATGAGCTCAATTATTTCTCCACCAAGGAA-4	NULL
'	NULL
)	NULL
,	NULL
MM	NULL
(	NULL
5-GATCCTTCCTCCAGATGAGCTCATGGGACGCTCCACCAAG	NULL
GAA-3	NULL
'	NULL
)	NULL
,	NULL
3	NULL
'	NULL
(	NULL
5-GATCCTITTCCTCCAGATGAGCTCATGGGTTTGACGAC	NULL
CAAGGAA-3	NULL
'	NULL
)	NULL
,	NULL
3'FL	NULL
(	NULL
5-GATCCTTCCTCCAGATGAGCTCATGGGTTTC	NULL
TCCGATAAGGAA-3	NULL
'	NULL
)	NULL
,	NULL
-117	NULL
(	NULL
5	NULL
%	NULL
-GATCACCGCTCCAGATGAGCTCATG	NULL
GGTTTCTCCACCAAGGAA-3	NULL
'	NULL
)	NULL
,	NULL
-113	NULL
(	NULL
5-GATCCITTCGCATAGATGAGC	NULL
TCATGGGTTTCTCCACCAAGGAA-3	NULL
'	NULL
)	NULL
,	NULL
and	NULL
NFAT	NULL
(	NULL
5-GATCCTGTATGA	NULL
AACAAATTITTCCTCTTTGGGC-3	NULL
'	NULL
)	NULL
.	NULL

Assembly	NULL
of	NULL
the	NULL
transcription	NULL
enhancer	NULL
complexes	NULL
and	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
.	NULL

Bactcrially	NULL
expressed	NULL
and	NULL
purified	NULL
ATF-2/Tun	NULL
,	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
NFATp	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
12	NULL
,	NULL
28	NULL
)	NULL
.	NULL

For	NULL
DNase	NULL
I	NULL
footprinting	NULL
exper-iments	NULL
,	NULL
TNF-	NULL
«	NULL
wild-type	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
mutated	NULL
promoter	NULL
fragments	NULL
as	NULL
indicated	NULL
(	NULL
20,000	NULL
cpm	NULL
)	NULL
spanning	NULL
the	NULL
sequences	NULL
from	NULL
-200	NULL
to	NULL
+87	NULL
were	NULL
end	NULL
labeled	NULL
at	NULL
the	NULL
noncoding	NULL
strand	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
proteins	NULL
in	NULL
20	NULL
pl	NULL
of	NULL
DB	NULL
buffer	NULL
CELL-TYPE-SPECIFIC	NULL
REGULATION	NULL
OF	NULL
THE	NULL
HUMAN	NULL
TNF-	NULL
«	NULL
GENE	NULL
5233	NULL
A.	NULL
I	NULL
_	NULL
PI	NULL
rar	NULL
1	NULL
UN	NULL
CsA	NULL
CsA	NULL
C.	NULL
rife	NULL
*	NULL
®	NULL
i	NULL
(	NULL
x3	NULL
)	NULL
8	NULL
-61	NULL
TNFa	NULL
.	NULL

--	NULL
-mI	NULL
m	NULL
--	NULL
P-	NULL
-P+I-UN	NULL
CsA	NULL
CsA	NULL
CsA	NULL
_	NULL
y-actin	NULL
1	NULL
2B	NULL
4	NULL
5	NULL
B	NULL
.	NULL

--	NULL
--	NULL
--	NULL
200	NULL
TNFo-	NULL
-	NULL
'	NULL
'	NULL
m-I-	NULL
-P-	NULL
-PiI-	NULL
’	NULL
’	NULL
'	NULL
’	NULL
'	NULL
UN	NULL
CsA	NULL
CsA	NULL
CsA	NULL
1	NULL
20	NULL
3	NULL
40	NULL
50	NULL
60	NULL
7	NULL
.	NULL

+61	NULL
+89	NULL
-61	NULL
TNF	NULL
-a	NULL
me-	NULL
car	NULL
(	NULL
x3/®-61	NULL
TNF-a	NULL
_	NULL
C	NULL
--	NULL
mea	NULL
TCO	NULL
)	NULL
99000000	NULL
10	NULL
2	NULL
3	NULL
40	NULL
50	NULL
60	NULL
7	NULL
FIG	NULL
.	NULL

1	NULL
.	NULL

Induction	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Autoradiogram	NULL
of	NULL
an	NULL
RNase	NULL
protection	NULL
assay	NULL
mapping	NULL
TNF-	NULL
«	NULL
and	NULL
y-actin	NULL
mRNAs	NULL
.	NULL

A20	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
(	NULL
I	NULL
)	NULL
or	NULL
P+I	NULL
for	NULL
30	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
y-actin	NULL
probe	NULL
was	NULL
made	NULL
to	NULL
have	NULL
a	NULL
specific	NULL
activity	NULL
one-fifth	NULL
of	NULL
the	NULL
specific	NULL
activity	NULL
of	NULL
the	NULL
mouse	NULL
TNF-a	NULL
probe	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Autoradiogram	NULL
of	NULL
a	NULL
CAT	NULL
assay	NULL
of	NULL
extracts	NULL
prepared	NULL
from	NULL
A20	NULL
cells	NULL
transfected	NULL
with	NULL
the	NULL
-200	NULL
TNF-	NULL
«	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

(	NULL
C	NULL
)	NULL
Autoradiogram	NULL
of	NULL
a	NULL
CAT	NULL
assay	NULL
of	NULL
extracts	NULL
prepared	NULL
from	NULL
A20	NULL
cells	NULL
after	NULL
transfection	NULL
with	NULL
a	NULL
construct	NULL
containing	NULL
six	NULL
copies	NULL
of	NULL
the	NULL
3	NULL
site	NULL
fused	NULL
to	NULL
the	NULL
-61	NULL
TNF-a	NULL
CAT	NULL
reporter	NULL
gene	NULL
.	NULL

In	NULL
panels	NULL
B	NULL
and	NULL
C	NULL
,	NULL
24	NULL
h	NULL
after	NULL
transfection	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
mock	NULL
induced	NULL
or	NULL
induced	NULL
with	NULL
ionomycin	NULL
(	NULL
I	NULL
)	NULL
,	NULL
PMA	NULL
(	NULL
P	NULL
)	NULL
,	NULL
or	NULL
P+I	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

and	NULL
digested	NULL
with	NULL
DNase	NULL
I	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
28	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
was	NULL
ethanol	NULL
precipitated	NULL
,	NULL
dried	NULL
,	NULL
resuspended	NULL
in	NULL
3	NULL
l	NULL
of	NULL
formamide	NULL
dye	NULL
,	NULL
and	NULL
loaded	NULL
onto	NULL
a	NULL
6	NULL
%	NULL
sequencing	NULL
gel	NULL
as	NULL
previously	NULL
described	NULL
(	NULL
12	NULL
)	NULL
.	NULL

RESULTS	NULL
The	NULL
TNF-a	NULL
«	NULL
gene	NULL
is	NULL
inducible	NULL
and	NULL
CsA	NULL
sensitive	NULL
in	NULL
the	NULL
murine	NULL
lymphoma	NULL
B-cell	NULL
line	NULL
A20	NULL
.	NULL

Given	NULL
that	NULL
PMA	NULL
and	NULL
ionomycin	NULL
together	NULL
are	NULL
capable	NULL
of	NULL
triggering	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
B	NULL
lymphocyte	NULL
cell	NULL
cycle	NULL
(	NULL
15	NULL
)	NULL
,	NULL
we	NULL
stimulated	NULL
A20	NULL
cells	NULL
with	NULL
ionomycin	NULL
or	NULL
with	NULL
P+I	NULL
to	NULL
recapitulate	NULL
B-cell	NULL
activation	NULL
.	NULL

Stimulation	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
TNF-	NULL
«	NULL
mRNA	NULL
were	NULL
determined	NULL
by	NULL
quantitative	NULL
RNase	NULL
protection	NULL
analysis	NULL
.	NULL

A20	NULL
cells	NULL
constitutively	NULL
express	NULL
a	NULL
low	NULL
level	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
,	NULL
lane	NULL
1	NULL
)	NULL
and	NULL
express	NULL
higher	NULL
TNF-	NULL
«	NULL
mRNA	NULL
levels	NULL
within	NULL
30	NULL
min	NULL
of	NULL
stimulation	NULL
with	NULL
ionomycin	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
B	NULL
cells	NULL
,	NULL
as	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
can	NULL
be	NULL
induced	NULL
by	NULL
calcium	NULL
flux	NULL
alone	NULL
and	NULL
does	NULL
not	NULL
require	NULL
protein	NULL
kinase	NULL
C	NULL
stimulation	NULL
.	NULL

However	NULL
,	NULL
the	NULL
addition	NULL
of	NULL
PMA	NULL
,	NULL
a	NULL
known	NULL
activator	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
,	NULL
superinduced	NULL
TNF-	NULL
«	NULL
mRNA	NULL
levels	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
and	NULL
induction	NULL
by	NULL
ionomycin	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
or	NULL
by	NULL
P+1I	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
was	NULL
blocked	NULL
by	NULL
pretreatment	NULL
of	NULL
the	NULL
cells	NULL
with	NULL
CsA	NULL
for	NULL
10	NULL
min	NULL
prior	NULL
to	NULL
stimulation	NULL
.	NULL

To	NULL
identify	NULL
the	NULL
TNF-a	NULL
promoter	NULL
sequences	NULL
required	NULL
for	NULL
the	NULL
transcriptional	NULL
activation	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
during	NULL
CsA-sensitive	NULL
B-cell	NULL
stimulation	NULL
,	NULL
we	NULL
transfected	NULL
A20	NULL
cells	NULL
with	NULL
a	NULL
TNF-a	NULL
CAT	NULL
reporter	NULL
construct	NULL
containing	NULL
200	NULL
nt	NULL
5	NULL
'	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
mRNA	NULL
cap	NULL
site	NULL
(	NULL
-200	NULL
TNF-	NULL
«	NULL
CAT	NULL
)	NULL
.	NULL

Increased	NULL
CAT	NULL
activity	NULL
was	NULL
detected	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
and	NULL
with	NULL
P+1I	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
,	NULL
lanes	NULL
2	NULL
and	NULL
6	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
and	NULL
this	NULL
induction	NULL
was	NULL
blocked	NULL
when	NULL
the	NULL
cells	NULL
were	NULL
pretreated	NULL
with	NULL
CsA	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
7	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
transfected	NULL
human	NULL
-200	NULL
TNF-	NULL
«	NULL
promoter	NULL
CAT	NULL
construct	NULL
parallels	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
endogenous	NULL
murine	NULL
A20	NULL
TNF-	NULL
«	NULL
gene	NULL
5234	NULL
TSAI	NULL
ET	NULL
AL	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

160	NULL
140	NULL
4	NULL
120	NULL
100	NULL
80	NULL
60	NULL
%	NULL
Relative	NULL
CAT	NULL
Activity	NULL
40	NULL
20	NULL
WT	NULL
A117	NULL
113	NULL
C30	NULL
CI	NULL
CRE	NULL
MM	NULL
-	NULL
3°	NULL
AP	NULL
]	NULL
SP	NULL
]	NULL
AP-2	NULL
x3	NULL
Mutation	NULL
~120	NULL
``	NULL
1	NULL
1,0	NULL
(	NULL
FE-105	NULL
)	NULL
K3	NULL
-	NULL
-90	NULL
-80	NULL
GACTAGGGQTchlzTCCAGAllgmwcATGGGTTT	NULL
?	NULL

+o	NULL
(	NULL
I3ACCAAGGAAGTTT	NULL
T	NULL
74	NULL
:	NULL
I	NULL
1	NULL
!	NULL

!	NULL

;	NULL
GcaT	NULL
;	NULL
|	NULL
117M	NULL
113M	NULL
C3M	NULL
C1M	NULL
5	NULL
'M	NULL
MM	NULL
3°M	NULL
70	NULL
AP-1	NULL
60	NULL
+50	NULL
SP-1	NULL
40	NULL
LT	NULL
_d	NULL
U	NULL
I	NULL
I	NULL
E	NULL
|	NULL
|	NULL
|	NULL
GACG	NULL
AP—Q-qo	NULL
TCCGCTGETTGAATGAT	NULL
TCT	NULL
T	NULL
TOCCCaCecTccTcToGcccca	NULL
GGGACATATAA	NULL
1	NULL
AP-1	NULL
SP-AP-2	NULL
;	NULL
GCcA	NULL
e	NULL
GaAG	NULL
|	NULL
e	NULL
IL-4	NULL
!	NULL

i	NULL
TTCA	NULL
FIG	NULL
.	NULL

2	NULL
.	NULL

Relative	NULL
activities	NULL
of	NULL
human	NULL
TNF-a	NULL
CAT	NULL
fusion	NULL
constructs	NULL
containing	NULL
mutations	NULL
in	NULL
the	NULL
CRE	NULL
,	NULL
x3	NULL
,	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
and	NULL
SP-1	NULL
sites	NULL
.	NULL

A20	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
WT	NULL
(	NULL
-200	NULL
TNF-	NULL
«	NULL
promoter	NULL
)	NULL
CAT	NULL
and	NULL
mutated	NULL
TNF-	NULL
«	NULL
promoter	NULL
CAT	NULL
plasmids	NULL
displayed	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

Twenty-four	NULL
hours	NULL
later	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
mock-stimulated	NULL
(	NULL
black	NULL
bars	NULL
)	NULL
or	NULL
induced	NULL
with	NULL
P+I	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
gray	NULL
bars	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
white	NULL
bars	NULL
)	NULL
of	NULL
CsA	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
,	NULL
and	NULL
the	NULL
percent	NULL
conversion	NULL
of	NULL
[	NULL
'*CJchloramphenicol	NULL
to	NULL
its	NULL
acetylated	NULL
forms	NULL
was	NULL
quantified	NULL
with	NULL
a	NULL
Betagen	NULL
Betascope	NULL
.	NULL

Result	NULL
for	NULL
cach	NULL
experiment	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
-200	NULL
WT-induced	NULL
level	NULL
(	NULL
100	NULL
%	NULL
)	NULL
and	NULL
then	NULL
averaged	NULL
and	NULL
plotted	NULL
.	NULL

Standard	NULL
deviations	NULL
are	NULL
represented	NULL
by	NULL
the	NULL
error	NULL
bars	NULL
.	NULL

The	NULL
results	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
patterns	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
various	NULL
constructs	NULL
were	NULL
consistent	NULL
between	NULL
experiments	NULL
.	NULL

The	NULL
average	NULL
values	NULL
for	NULL
fold	NULL
induction	NULL
for	NULL
the	NULL
displayed	NULL
constructs	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
WT	NULL
,	NULL
11.23	NULL
;	NULL
-117	NULL
,	NULL
15.7	NULL
;	NULL
-113	NULL
,	NULL
19.4	NULL
;	NULL
C3	NULL
,	NULL
9.7	NULL
;	NULL
C1	NULL
,	NULL
4.0	NULL
;	NULL
5	NULL
'	NULL
,	NULL
2.1	NULL
;	NULL
MM	NULL
,	NULL
8.3	NULL
;	NULL
3	NULL
'	NULL
,	NULL
6.5	NULL
;	NULL
AP-1	NULL
,	NULL
6.2	NULL
;	NULL
SP-1	NULL
,	NULL
40.6	NULL
;	NULL
and	NULL
AP-2	NULL
,	NULL
11.9	NULL
.	NULL

The	NULL
CRE	NULL
,	NULL
x3	NULL
,	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
and	NULL
SP-1	NULL
sites	NULL
are	NULL
underlined	NULL
.	NULL

(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
when	NULL
the	NULL
-200	NULL
TNF-	NULL
«	NULL
CAT	NULL
construct	NULL
was	NULL
transfected	NULL
into	NULL
the	NULL
human	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
B-cell	NULL
line	NULL
Raji	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
human	NULL
TNF-	NULL
«	NULL
gene	NULL
promoter	NULL
contains	NULL
three	NULL
NF-kB	NULL
consensus	NULL
sequences	NULL
,	NULL
called	NULL
x1	NULL
(	NULL
-587	NULL
to	NULL
-576	NULL
nt	NULL
)	NULL
,	NULL
2	NULL
(	NULL
-210	NULL
to	NULL
-202	NULL
nt	NULL
)	NULL
,	NULL
and	NULL
3	NULL
(	NULL
-98	NULL
to	NULL
-=87	NULL
nt	NULL
)	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
studies	NULL
in	NULL
other	NULL
cell	NULL
types	NULL
(	NULL
6	NULL
,	NULL
8	NULL
,	NULL
9	NULL
)	NULL
and	NULL
with	NULL
other	NULL
inducers	NULL
,	NULL
deletion	NULL
of	NULL
x1	NULL
and	NULL
x2	NULL
did	NULL
not	NULL
affect	NULL
inducibility	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
and	NULL
200	NULL
nt	NULL
upstream	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
transcription	NULL
start	NULL
site	NULL
are	NULL
sufficient	NULL
for	NULL
maximal	NULL
inducibility	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
A20	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
and	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
x3	NULL
site	NULL
,	NULL
but	NULL
not	NULL
the	NULL
x1	NULL
or	NULL
2	NULL
site	NULL
,	NULL
is	NULL
included	NULL
in	NULL
the	NULL
-200	NULL
TNF-a	NULL
CAT	NULL
reporter	NULL
construct	NULL
.	NULL

The	NULL
x3	NULL
site	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
the	NULL
x1	NULL
and	NULL
<	NULL
2	NULL
sites	NULL
,	NULL
has	NULL
been	NULL
implicated	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
a	NULL
variety	NULL
of	NULL
cell	NULL
types	NULL
(	NULL
6	NULL
,	NULL
8	NULL
,	NULL
29	NULL
)	NULL
.	NULL

In	NULL
the	NULL
T-cell	NULL
clone	NULL
Ar-5	NULL
,	NULL
the	NULL
x3	NULL
site	NULL
binds	NULL
two	NULL
molecules	NULL
of	NULL
NFAT	NULL
p	NULL
and	NULL
an	NULL
immediately	NULL
adjacent	NULL
CRE	NULL
binds	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
and	NULL
mediates	NULL
the	NULL
CsA-sensitive	NULL
inducible	NULL
regulation	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
(	NULL
8	NULL
,	NULL
29	NULL
)	NULL
.	NULL

We	NULL
were	NULL
therefore	NULL
surprised	NULL
to	NULL
find	NULL
that	NULL
the	NULL
same	NULL
construct	NULL
,	NULL
(	NULL
x3	NULL
)	NULL
5-61	NULL
TNF-a	NULL
,	NULL
which	NULL
carries	NULL
six	NULL
copies	NULL
of	NULL
the	NULL
x3	NULL
site	NULL
fused	NULL
to	NULL
a	NULL
truncated	NULL
-61	NULL
TNF-	NULL
«	NULL
promoter	NULL
and	NULL
is	NULL
highly	NULL
inducible	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
,	NULL
was	NULL
not	NULL
inducible	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
although	NULL
the	NULL
intact	NULL
TNF-	NULL
«	NULL
promoter	NULL
was	NULL
inducible	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
in	NULL
the	NULL
role	NULL
that	NULL
the	NULL
x3	NULL
site	NULL
played	NULL
within	NULL
the	NULL
intact	NULL
TNF-	NULL
«	NULL
promoter	NULL
in	NULL
the	NULL
CsA-sensitive	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
x3	NULL
and	NULL
CRE	NULL
sites	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
TNF-	NULL
«	NULL
gene	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

To	NULL
characterize	NULL
the	NULL
role	NULL
of	NULL
the	NULL
x3	NULL
and	NULL
abutting	NULL
CRE	NULL
sites	NULL
in	NULL
the	NULL
inducible	NULL
regulation	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
in	NULL
A20	NULL
cells	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
effects	NULL
of	NULL
site-directed	NULL
mutations	NULL
introduced	NULL
into	NULL
these	NULL
sites	NULL
on	NULL
TNF-	NULL
«	NULL
promoter	NULL
activity	NULL
in	NULL
A20	NULL
cells	NULL
.	NULL

A	NULL
mutation	NULL
introduced	NULL
into	NULL
the	NULL
5	NULL
'	NULL
aspect	NULL
of	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
A	NULL
I_K3|	NULL
;	NULL
L	NULL
]	NULL
—|	NULL
<	NULL
8	NULL
-	NULL
$	NULL
z	NULL
§§	NULL
7	NULL
F	NULL
322615	NULL
``	NULL
XC	NULL
Ea	NULL
<	NULL
T	NULL
ns	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
17	NULL
CRE	NULL
;	NULL
x3	NULL
_	NULL
8	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
CTTCCTCCAGATGAGCTCATGGGTTTCTCCACCAAGGAA	NULL
CELL-TYPE-SPECIFIC	NULL
REGULATION	NULL
OF	NULL
THE	NULL
HUMAN	NULL
TNF-	NULL
«	NULL
GENE	NULL
5235	NULL
PMA+lono	NULL
--	NULL
-	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
A17	NULL
___	NULL
®3	NULL
__	NULL
``	NULL
T8	NULL
|	NULL
7M	NULL
Acco	NULL
113M	NULL
Gcat	NULL
CaM	NULL
GTCA	NULL
ciM	NULL
AGC	NULL
5M	NULL
ATTA	NULL
MM	NULL
Aco	NULL
a	NULL
cace	NULL
3FL	NULL
Gat	NULL
FIG	NULL
.	NULL

3	NULL
.	NULL

Binding	NULL
of	NULL
nuclear	NULL
factors	NULL
to	NULL
the	NULL
probe	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
unstimulated	NULL
(	NULL
UN	NULL
)	NULL
cells	NULL
or	NULL
cells	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
(	NULL
Iono	NULL
)	NULL
or	NULL
P+I	NULL
for	NULL
30	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

The	NULL
x3	NULL
(	NULL
L	NULL
)	NULL
probe	NULL
contains	NULL
-117	NULL
to	NULL
-78	NULL
nt	NULL
relative	NULL
to	NULL
the	NULL
mRNA	NULL
cap	NULL
site	NULL
and	NULL
is	NULL
diagrammed	NULL
at	NULL
the	NULL
bottom	NULL
of	NULL
panel	NULL
B.	NULL
Nonspecific	NULL
(	NULL
NS	NULL
)	NULL
binding	NULL
complexes	NULL
are	NULL
bracketed	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Binding	NULL
of	NULL
factors	NULL
to	NULL
WT	NULL
and	NULL
mutated	NULL
oligonucleotides	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
A20	NULL
cells	NULL
stimulated	NULL
with	NULL
P+I	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
an	NULL
EMSA	NULL
was	NULL
performed	NULL
with	NULL
the	NULL
probes	NULL
displayed	NULL
at	NULL
the	NULL
bottom	NULL
.	NULL

Nonspecific	NULL
(	NULL
NS	NULL
)	NULL
binding	NULL
complexes	NULL
are	NULL
bracketed	NULL
.	NULL

the	NULL
«	NULL
3	NULL
site	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
-200	NULL
TNF-	NULL
«	NULL
promoter	NULL
,	NULL
called	NULL
5	NULL
'M	NULL
,	NULL
resulted	NULL
in	NULL
a	NULL
dramatic	NULL
reduction	NULL
of	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
mutation	NULL
of	NULL
the	NULL
3	NULL
'	NULL
aspect	NULL
of	NULL
the	NULL
«	NULL
3	NULL
site	NULL
,	NULL
called	NULL
3	NULL
'M	NULL
,	NULL
did	NULL
not	NULL
significantly	NULL
affect	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

These	NULL
results	NULL
were	NULL
different	NULL
from	NULL
those	NULL
obtained	NULL
for	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
both	NULL
of	NULL
these	NULL
mutations	NULL
eliminated	NULL
ionomycin	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
3	NULL
'	NULL
mutation	NULL
completely	NULL
eliminates	NULL
NFATp	NULL
binding	NULL
to	NULL
x3	NULL
(	NULL
17	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
3	NULL
'M	NULL
mutation	NULL
does	NULL
not	NULL
affect	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
in	NULL
A20	NULL
cells	NULL
suggested	NULL
that	NULL
NFATp	NULL
is	NULL
not	NULL
involved	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
TNF-a	NULL
via	NULL
the	NULL
x3	NULL
site	NULL
in	NULL
A20	NULL
cells	NULL
.	NULL

To	NULL
examine	NULL
the	NULL
role	NULL
of	NULL
the	NULL
CRE	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
activities	NULL
of	NULL
constructs	NULL
carrying	NULL
mutations	NULL
in	NULL
the	NULL
CRE	NULL
site	NULL
in	NULL
A20	NULL
cells	NULL
.	NULL

The	NULL
C1	NULL
mutation	NULL
,	NULL
which	NULL
mutates	NULL
the	NULL
3	NULL
'	NULL
aspect	NULL
of	NULL
the	NULL
CRE	NULL
dramatically	NULL
,	NULL
decreased	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Also	NULL
,	NULL
a	NULL
mutation	NULL
of	NULL
the	NULL
5	NULL
'	NULL
aspect	NULL
of	NULL
the	NULL
CRE	NULL
,	NULL
which	NULL
mutates	NULL
only	NULL
the	NULL
first	NULL
T	NULL
of	NULL
the	NULL
CRE	NULL
,	NULL
called	NULL
C3	NULL
,	NULL
also	NULL
resulted	NULL
in	NULL
a	NULL
decrease	NULL
of	NULL
approximately	NULL
50	NULL
%	NULL
of	NULL
CAT	NULL
activity	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

The	NULL
specificities	NULL
of	NULL
these	NULL
effects	NULL
were	NULL
demonstrated	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
mutations	NULL
introduced	NULL
into	NULL
the	NULL
AP-1	NULL
,	NULL
AP-2	NULL
,	NULL
and	NULL
SP-1	NULL
consensus	NULL
sequences	NULL
located	NULL
downstream	NULL
of	NULL
the	NULL
x3	NULL
element	NULL
had	NULL
no	NULL
detrimental	NULL
effect	NULL
on	NULL
gene	NULL
induction	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

We	NULL
note	NULL
that	NULL
the	NULL
same	NULL
pattern	NULL
of	NULL
expression	NULL
for	NULL
all	NULL
of	NULL
the	NULL
mutant	NULL
constructs	NULL
displayed	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
was	NULL
obtained	NULL
when	NULL
ionomycin	NULL
alone	NULL
was	NULL
used	NULL
as	NULL
the	NULL
inducer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
these	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
a	NULL
critical	NULL
role	NULL
of	NULL
the	NULL
5	NULL
'	NULL
aspect	NULL
of	NULL
x3	NULL
and	NULL
the	NULL
CRE	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
in	NULL
A20	NULL
cells	NULL
.	NULL

The	NULL
composite	NULL
x3/CRE	NULL
site	NULL
binds	NULL
a	NULL
constitutive	NULL
complex	NULL
.	NULL

To	NULL
test	NULL
the	NULL
binding	NULL
activities	NULL
of	NULL
the	NULL
k3/CRE	NULL
site	NULL
in	NULL
A20	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
called	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
,	NULL
matching	NULL
the	NULL
sequences	NULL
from	NULL
-117	NULL
to	NULL
-78	NULL
nt	NULL
and	NULL
performed	NULL
an	NULL
EMSA	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
A20	NULL
cells	NULL
that	NULL
had	NULL
been	NULL
either	NULL
mock	NULL
stimulated	NULL
or	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
or	NULL
P+1I	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
A20	NULL
nuclear	NULL
extracts	NULL
the	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
probe	NULL
bound	NULL
a	NULL
major	NULL
constitutive	NULL
complex	NULL
,	NULL
which	NULL
is	NULL
neither	NULL
inducible	NULL
nor	NULL
CsA	NULL
sensitive	NULL
(	NULL
Fig	NULL
.	NULL

3A	NULL
)	NULL
.	NULL

This	NULL
pattern	NULL
is	NULL
in	NULL
dramatic	NULL
contrast	NULL
to	NULL
the	NULL
binding	NULL
pattern	NULL
of	NULL
the	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
probe	NULL
in	NULL
Ar-5	NULL
T	NULL
cell	NULL
nuclear	NULL
extracts	NULL
,	NULL
in	NULL
which	NULL
the	NULL
same	NULL
probe	NULL
gives	NULL
rise	NULL
to	NULL
two	NULL
inducible	NULL
NFAT	NULL
p	NULL
complexes	NULL
and	NULL
a	NULL
constitutive	NULL
complex	NULL
made	NULL
up	NULL
of	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
(	NULL
8	NULL
,	NULL
23	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
oligonucleotide	NULL
displays	NULL
different	NULL
binding	NULL
patterns	NULL
in	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
A20	NULL
B	NULL
cells	NULL
and	NULL
those	NULL
derived	NULL
from	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

Mutations	NULL
that	NULL
abrogate	NULL
TNF-a	NULL
@	NULL
gene	NULL
induction	NULL
also	NULL
interfere	NULL
with	NULL
x3	NULL
(	NULL
L	NULL
)	NULL
binding	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
same	NULL
mutations	NULL
which	NULL
decrease	NULL
gene	NULL
expression	NULL
in	NULL
vivo	NULL
also	NULL
alter	NULL
binding	NULL
patterns	NULL
of	NULL
nuclear	NULL
proteins	NULL
in	NULL
vitro	NULL
,	NULL
we	NULL
performed	NULL
gel	NULL
shift	NULL
assays	NULL
with	NULL
probes	NULL
carrying	NULL
those	NULL
mutations	NULL
used	NULL
in	NULL
the	NULL
transfection	NULL
assays	NULL
.	NULL

The	NULL
CRE	NULL
mutations	NULL
C1	NULL
and	NULL
C3	NULL
,	NULL
which	NULL
abrogated	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
,	NULL
disrupted	NULL
binding	NULL
to	NULL
the	NULL
uppermost	NULL
complex	NULL
,	NULL
indicating	NULL
that	NULL
this	NULL
is	NULL
the	NULL
CRE-binding	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
4	NULL
and	NULL
5	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
CRE-binding	NULL
complex	NULL
is	NULL
completely	NULL
abrogated	NULL
by	NULL
the	NULL
C3	NULL
mutation	NULL
,	NULL
it	NULL
lowers	NULL
inducibility	NULL
of	NULL
the	NULL
TNF-a	NULL
promoter	NULL
by	NULL
approximately	NULL
50	NULL
%	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
C3	NULL
mutation	NULL
's	NULL
effect	NULL
in	NULL
the	NULL
transfection	NULL
assay	NULL
,	NULL
although	NULL
not	NULL
completely	NULL
concordant	NULL
,	NULL
is	NULL
correlated	NULL
with	NULL
the	NULL
disruption	NULL
of	NULL
binding	NULL
to	NULL
this	NULL
complex	NULL
.	NULL

We	NULL
note	NULL
that	NULL
the	NULL
binding	NULL
assay	NULL
is	NULL
done	NULL
with	NULL
an	NULL
isolated	NULL
promoter	NULL
element	NULL
,	NULL
the	NULL
CRE/x3	NULL
site	NULL
,	NULL
and	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
is	NULL
dependent	NULL
on	NULL
multiple	NULL
elements	NULL
in	NULL
the	NULL
transfection	NULL
assay	NULL
.	NULL

The	NULL
oligonucleotide	NULL
carrying	NULL
the	NULL
5	NULL
'	NULL
mutation	NULL
in	NULL
the	NULL
x3	NULL
site	NULL
,	NULL
5	NULL
'M	NULL
,	NULL
which	NULL
abrogated	NULL
gene	NULL
induction	NULL
in	NULL
the	NULL
transfection	NULL
assay	NULL
,	NULL
also	NULL
displayed	NULL
markedly	NULL
decreased	NULL
binding	NULL
to	NULL
the	NULL
CRE-binding	NULL
complex	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
binding	NULL
of	NULL
this	NULL
complex	NULL
to	NULL
the	NULL
CRE	NULL
was	NULL
demonstrated	NULL
by	NULL
the	NULL
inability	NULL
of	NULL
probes	NULL
bearing	NULL
mutations	NULL
outside	NULL
of	NULL
the	NULL
CRE	NULL
(	NULL
-117	NULL
,	NULL
-113	NULL
,	NULL
MM	NULL
,	NULL
3	NULL
'M	NULL
,	NULL
and	NULL
3'FL	NULL
)	NULL
to	NULL
affect	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
CRE-binding	NULL
complex	NULL
;	NULL
the	NULL
binding	NULL
patterns	NULL
of	NULL
these	NULL
mutant	NULL
probes	NULL
were	NULL
similar	NULL
to	NULL
the	NULL
binding	NULL
pattern	NULL
of	NULL
the	NULL
wild-type	NULL
©3	NULL
(	NULL
L	NULL
)	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
,	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
and	NULL
7	NULL
to	NULL
9	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
CRE	NULL
and	NULL
the	NULL
5	NULL
'	NULL
aspect	NULL
but	NULL
not	NULL
the	NULL
3	NULL
'	NULL
aspect	NULL
of	NULL
the	NULL
3	NULL
site	NULL
are	NULL
required	NULL
for	NULL
5236	NULL
TSAI	NULL
ET	NULL
AL	NULL
.	NULL

g-	NULL
-61	NULL
to	NULL
-26	NULL
Probe	NULL
--	NULL
-K3	NULL
(	NULL
L	NULL
)	NULL
--	NULL
-	NULL
-=	NULL
Cu	NULL
-	NULL
m	NULL
o	NULL
of	NULL
E	NULL
m	NULL
o	NULL
&	NULL
a	NULL
€	NULL
&	NULL
-	NULL
5	NULL
3	NULL
6	NULL
&	NULL
<	NULL
6	NULL
4	NULL
4	NULL
<	NULL
3	NULL
46	NULL
3	NULL
3	NULL
Antibody	NULL
-	NULL
3	NULL
3	NULL
s	NULL
s	NULL
38	NULL
-	NULL
s	NULL
3s	NULL
s	NULL
s	NULL
8	NULL
«	NULL
-	NULL
a	NULL
dite	NULL
ra	NULL
®	NULL
#	NULL
4	NULL
.	NULL

f	NULL
KE	NULL
C	NULL
2a	NULL
Jun	NULL
C_	NULL
C_	NULL
1	NULL
2	NULL
3	NULL
4	NULL
506	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
FIG	NULL
.	NULL

4	NULL
.	NULL

Reactivities	NULL
of	NULL
antibodies	NULL
to	NULL
ATF-2	NULL
and	NULL
Jun	NULL
family	NULL
members	NULL
with	NULL
the	NULL
«	NULL
3	NULL
(	NULL
L	NULL
)	NULL
-binding	NULL
complex	NULL
.	NULL

Extracts	NULL
from	NULL
A20	NULL
cells	NULL
stimulated	NULL
with	NULL
P+I	NULL
for	NULL
30	NULL
min	NULL
were	NULL
assayed	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
©3	NULL
(	NULL
L	NULL
)	NULL
or	NULL
to	NULL
the	NULL
-61	NULL
to	NULL
-26	NULL
nt	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
in	NULL
the	NULL
indicated	NULL
antibodies	NULL
.	NULL

The	NULL
-61	NULL
to	NULL
-27	NULL
nt	NULL
oligonucleotide	NULL
probe	NULL
,	NULL
which	NULL
binds	NULL
a	NULL
constitutive	NULL
factor	NULL
in	NULL
A20	NULL
cells	NULL
,	NULL
was	NULL
used	NULL
as	NULL
a	NULL
control	NULL
for	NULL
the	NULL
specificity	NULL
of	NULL
the	NULL
ATF-2	NULL
and	NULL
Jun	NULL
antibodies	NULL
in	NULL
the	NULL
supershift	NULL
assay	NULL
.	NULL

both	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
-binding	NULL
complex	NULL
in	NULL
vitro	NULL
and	NULL
the	NULL
inducible	NULL
expression	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
vivo	NULL
in	NULL
A20	NULL
cells	NULL
.	NULL

ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
bind	NULL
to	NULL
the	NULL
x3	NULL
(	NULL
L	NULL
)	NULL
oligonucleotide	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

Previously	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
derived	NULL
from	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
specifically	NULL
associate	NULL
with	NULL
the	NULL
CRE	NULL
included	NULL
in	NULL
the	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
oligonucleotide	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Given	NULL
the	NULL
importance	NULL
of	NULL
the	NULL
CRE	NULL
both	NULL
in	NULL
TNF-a	NULL
gene	NULL
regulation	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
and	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
the	NULL
major	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
-binding	NULL
complex	NULL
,	NULL
we	NULL
were	NULL
interested	NULL
in	NULL
determining	NULL
whether	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
present	NULL
in	NULL
A20	NULL
nuclear	NULL
extracts	NULL
also	NULL
assembled	NULL
on	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
.	NULL

Figure	NULL
4	NULL
shows	NULL
that	NULL
antibodies	NULL
to	NULL
ATF-2	NULL
(	NULL
lane	NULL
2	NULL
)	NULL
,	NULL
Jun	NULL
family	NULL
members	NULL
(	NULL
lane	NULL
3	NULL
)	NULL
,	NULL
and	NULL
c-Jun	NULL
(	NULL
lane	NULL
4	NULL
)	NULL
,	NULL
reacted	NULL
with	NULL
the	NULL
CRE-binding	NULL
complex	NULL
in	NULL
A20	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
this	NULL
reaction	NULL
was	NULL
verified	NULL
by	NULL
the	NULL
use	NULL
of	NULL
a	NULL
probe	NULL
matching	NULL
the	NULL
sequences	NULL
from	NULL
-61	NULL
to	NULL
-26	NULL
nt	NULL
relative	NULL
to	NULL
the	NULL
TNF-a	NULL
mRNA	NULL
start	NULL
site	NULL
;	NULL
we	NULL
found	NULL
that	NULL
none	NULL
of	NULL
the	NULL
antibodies	NULL
reacted	NULL
with	NULL
the	NULL
complexes	NULL
bound	NULL
to	NULL
this	NULL
probe	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
12	NULL
)	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
the	NULL
ATF-2	NULL
and	NULL
Jun	NULL
antibodies	NULL
reacted	NULL
with	NULL
the	NULL
entire	NULL
CRE/xk3	NULL
binding	NULL
complex	NULL
suggested	NULL
that	NULL
ATF-2	NULL
and	NULL
c-Jun	NULL
are	NULL
the	NULL
major	NULL
components	NULL
of	NULL
the	NULL
A20	NULL
CRE/x3-binding	NULL
complex	NULL
.	NULL

Again	NULL
,	NULL
these	NULL
results	NULL
are	NULL
in	NULL
contrast	NULL
to	NULL
results	NULL
from	NULL
T	NULL
cells	NULL
,	NULL
in	NULL
which	NULL
a	NULL
discrete	NULL
CRE-binding	NULL
complex	NULL
and	NULL
two	NULL
NFATp-binding	NULL
complexes	NULL
are	NULL
detectable	NULL
(	NULL
29	NULL
)	NULL
.	NULL

NFATp	NULL
and	NULL
NF-B	NULL
proteins	NULL
do	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
x3	NULL
(	NULL
L	NULL
)	NULL
oligonucleotide	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
the	NULL
x3	NULL
element	NULL
is	NULL
recognized	NULL
by	NULL
NFAT	NULL
p	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
23	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
a	NULL
mutation	NULL
that	NULL
disrupts	NULL
binding	NULL
of	NULL
NFATp	NULL
to	NULL
«	NULL
3	NULL
in	NULL
T	NULL
cells	NULL
also	NULL
abrogates	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
these	NULL
cells	NULL
(	NULL
8	NULL
,	NULL
17	NULL
)	NULL
.	NULL

However	NULL
,	NULL
as	NULL
we	NULL
showed	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
and	NULL
3	NULL
,	NULL
the	NULL
same	NULL
mutation	NULL
,	NULL
3	NULL
'M	NULL
,	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
or	NULL
upon	NULL
the	NULL
binding	NULL
of	NULL
the	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
-binding	NULL
complex	NULL
in	NULL
A20	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
these	NULL
results	NULL
suggested	NULL
either	NULL
that	NULL
NFATp	NULL
is	NULL
not	NULL
present	NULL
in	NULL
A20	NULL
cells	NULL
or	NULL
that	NULL
NFATp	NULL
is	NULL
present	NULL
but	NULL
not	NULL
required	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
TNF-a	NULL
via	NULL
the	NULL
x3	NULL
site	NULL
in	NULL
A20	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
NFATp	NULL
was	NULL
present	NULL
in	NULL
A20	NULL
cells	NULL
,	NULL
we	NULL
used	NULL
a	NULL
probe	NULL
matching	NULL
an	NULL
NFAT	NULL
site	NULL
from	NULL
the	NULL
murine	NULL
IL-2	NULL
promoter	NULL
and	NULL
antibodies	NULL
to	NULL
NFATp	NULL
in	NULL
a	NULL
gel	NULL
shift	NULL
analysis	NULL
using	NULL
A20	NULL
nuclear	NULL
extracts	NULL
.	NULL

The	NULL
NFAT	NULL
probe	NULL
formed	NULL
a	NULL
complex	NULL
in	NULL
stimulated	NULL
A20	NULL
nuclear	NULL
extracts	NULL
that	NULL
was	NULL
recognized	NULL
by	NULL
an	NULL
antibody	NULL
to	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

Probe	NULL
[	NULL
NFAT	NULL
1	NULL
[	NULL
K3	NULL
(	NULL
L	NULL
)	NULL
]	NULL
-P+I-7	NULL
p-P+I-4	NULL
rﬂNFATj	NULL
rQNFAT-r	NULL
§	NULL
+	NULL
&	NULL
:	NULL
i5	NULL
=	NULL
15	NULL
kis	NULL
z-	NULL
ol	NULL
Li	NULL
z-	NULL
J	NULL
g	NULL
z	NULL
coc	NULL
g	NULL
z	NULL
a.	NULL
oa	NULL
.	NULL

a_	NULL
3	NULL
+	NULL
+	NULL
a	NULL
8	NULL
+o	NULL
+	NULL
n	NULL
:	NULL
-	NULL
*~	NULL
yo	NULL
ae	NULL
wo	NULL
a	NULL
om	NULL
mn	NULL
-__	NULL
C	NULL
ke	NULL
ee	NULL
eee	NULL
~	NULL
RTVT	NULL
102	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
9	NULL
10	NULL
11	NULL
12	NULL
FIG	NULL
.	NULL

5	NULL
.	NULL

Reactivities	NULL
of	NULL
an	NULL
NFATp	NULL
antibody	NULL
with	NULL
nuclear	NULL
«	NULL
3	NULL
(	NULL
L	NULL
)	NULL
-binding	NULL
complexes	NULL
from	NULL
A20	NULL
cells	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
A20	NULL
cells	NULL
that	NULL
were	NULL
stimulated	NULL
for	NULL
30	NULL
min	NULL
with	NULL
P+1I	NULL
and	NULL
were	NULL
assayed	NULL
for	NULL
binding	NULL
©3	NULL
(	NULL
L	NULL
)	NULL
or	NULL
NFAT	NULL
oligonucleotides	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
an	NULL
NFATp	NULL
antibody	NULL
(	NULL
«	NULL
NFATp	NULL
)	NULL
and	NULL
the	NULL
cognate	NULL
peptide	NULL
to	NULL
which	NULL
the	NULL
antibody	NULL
was	NULL
raised	NULL
(	NULL
P1	NULL
)	NULL
or	NULL
an	NULL
irrelevant	NULL
peptide	NULL
(	NULL
P2	NULL
)	NULL
,	NULL
as	NULL
indicated	NULL
.	NULL

PreImm	NULL
,	NULL
preimmune	NULL
serum	NULL
.	NULL

NFATp	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
,	NULL
lanes	NULL
3	NULL
and	NULL
4	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
the	NULL
cognate	NULL
peptide	NULL
(	NULL
P1	NULL
)	NULL
to	NULL
which	NULL
the	NULL
NFATp	NULL
antibody	NULL
was	NULL
raised	NULL
reversed	NULL
the	NULL
supershift	NULL
(	NULL
lane	NULL
5	NULL
)	NULL
,	NULL
whereas	NULL
addition	NULL
of	NULL
a	NULL
noncognate	NULL
peptide	NULL
(	NULL
P2	NULL
)	NULL
did	NULL
not	NULL
(	NULL
lane	NULL
6	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
antibody	NULL
to	NULL
NFATp	NULL
failed	NULL
to	NULL
supershift	NULL
the	NULL
complex	NULL
bound	NULL
to	NULL
the	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
probe	NULL
(	NULL
lanes	NULL
9	NULL
to	NULL
12	NULL
)	NULL
,	NULL
indicating	NULL
that	NULL
although	NULL
NFATp	NULL
is	NULL
present	NULL
in	NULL
A20	NULL
cells	NULL
,	NULL
it	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
x3	NULL
site	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

Given	NULL
that	NULL
the	NULL
x3	NULL
site	NULL
matches	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
sequence	NULL
(	NULL
6	NULL
)	NULL
,	NULL
we	NULL
investigated	NULL
the	NULL
possibility	NULL
that	NULL
NF-kB	NULL
proteins	NULL
present	NULL
in	NULL
A20	NULL
cells	NULL
bind	NULL
to	NULL
the	NULL
x3	NULL
site	NULL
.	NULL

As	NULL
a	NULL
control	NULL
,	NULL
we	NULL
used	NULL
the	NULL
NF-kB	NULL
site	NULL
taken	NULL
from	NULL
the	NULL
murine	NULL
x	NULL
light-chain	NULL
enhancer	NULL
as	NULL
a	NULL
probe	NULL
and	NULL
compared	NULL
its	NULL
binding	NULL
activity	NULL
in	NULL
A20	NULL
nuclear	NULL
extracts	NULL
with	NULL
the	NULL
binding	NULL
activity	NULL
of	NULL
the	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
probe	NULL
.	NULL

Although	NULL
antibodies	NULL
to	NULL
p50	NULL
,	NULL
p65	NULL
,	NULL
and	NULL
c-Rel	NULL
recognized	NULL
the	NULL
complexes	NULL
bound	NULL
to	NULL
the	NULL
kB	NULL
control	NULL
probe	NULL
,	NULL
none	NULL
of	NULL
the	NULL
antibodies	NULL
reacted	NULL
with	NULL
the	NULL
proteins	NULL
bound	NULL
to	NULL
the	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
probe	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
tested	NULL
antibodies	NULL
to	NULL
ReIB	NULL
and	NULL
p52	NULL
,	NULL
which	NULL
also	NULL
did	NULL
not	NULL
react	NULL
with	NULL
the	NULL
k3-binding	NULL
factors	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
NF-kB	NULL
proteins	NULL
or	NULL
NFATp	NULL
do	NULL
not	NULL
bind	NULL
to	NULL
the	NULL
TNF-a	NULL
x3	NULL
site	NULL
in	NULL
A20	NULL
cells	NULL
.	NULL

Transcriptional	NULL
activation	NULL
of	NULL
synthetic	NULL
promoters	NULL
by	NULL
3	NULL
(	NULL
L	NULL
)	NULL
is	NULL
cell	NULL
type	NULL
specific	NULL
.	NULL

In	NULL
the	NULL
T-cell	NULL
clone	NULL
Ar-5	NULL
,	NULL
six	NULL
copies	NULL
of	NULL
the	NULL
x3	NULL
site	NULL
cloned	NULL
upstream	NULL
of	NULL
a	NULL
truncated	NULL
-61	NULL
TNF-	NULL
«	NULL
gene	NULL
promoter	NULL
confers	NULL
inducibility	NULL
by	NULL
T-cell	NULL
receptor	NULL
ligands	NULL
or	NULL
by	NULL
calcium	NULL
ionophore	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
x3	NULL
element	NULL
included	NULL
in	NULL
the	NULL
(	NULL
x3	NULL
)	NULL
°-61	NULL
TNF-a	NULL
«	NULL
CAT	NULL
construct	NULL
extends	NULL
from	NULL
-105	NULL
to	NULL
-85	NULL
nt	NULL
relative	NULL
to	NULL
the	NULL
TNF-	NULL
«	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

This	NULL
oligonucleotide	NULL
binds	NULL
two	NULL
molecules	NULL
of	NULL
NFATp	NULL
but	NULL
does	NULL
not	NULL
contain	NULL
an	NULL
intact	NULL
CRE	NULL
site	NULL
and	NULL
hence	NULL
does	NULL
not	NULL
bind	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
(	NULL
«	NULL
3	NULL
)	NULL
°	NULL
=61	NULL
TNF-	NULL
«	NULL
CAT	NULL
reporter	NULL
construct	NULL
is	NULL
highly	NULL
inducible	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
,	NULL
this	NULL
construct	NULL
was	NULL
not	NULL
inducible	NULL
by	NULL
ionomycin	NULL
or	NULL
by	NULL
P+I	NULL
in	NULL
A20	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1C	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
oligonucleotide	NULL
,	NULL
which	NULL
extends	NULL
from	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
A20	NULL
B	NULL
cells	NULL
I	NULL
Un	NULL
P+	NULL
m	NULL
P+L/CsA	NULL
CELL-TYPE-SPECIFIC	NULL
REGULATION	NULL
OF	NULL
THE	NULL
HUMAN	NULL
TNF-	NULL
«	NULL
GENE	NULL
5237	NULL
%	NULL
Relative	NULL
CAT	NULL
Activity	NULL
L1	NULL
Promoter	NULL
WT	NULL
L2	NULL
Ar-5	NULL
T	NULL
cells	NULL
(	NULL
3M	NULL
)	NULL
2	NULL
I	NULL
.	NULL

Un	NULL
P+	NULL
]	NULL
.	NULL

F+L/CsA	NULL
I	NULL
907	NULL
%	NULL
Relative	NULL
CAT	NULL
Activity	NULL
WT	NULL
L1	NULL
Promoter	NULL
L2	NULL
(	NULL
3M	NULL
)	NULL
2	NULL
FIG	NULL
.	NULL

6	NULL
.	NULL

Activation	NULL
of	NULL
synthetic	NULL
TNF-a	NULL
promoters	NULL
containing	NULL
«	NULL
3	NULL
(	NULL
L	NULL
)	NULL
multimers	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
and	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

A20	NULL
B	NULL
cells	NULL
or	NULL
Ar-5	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
-200	NULL
TNF-a	NULL
promoter	NULL
CAT	NULL
construct	NULL
(	NULL
WT	NULL
)	NULL
or	NULL
with	NULL
the	NULL
truncated	NULL
-39	NULL
TNF-a	NULL
CAT	NULL
construct	NULL
containing	NULL
either	NULL
one	NULL
or	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
x3	NULL
(	NULL
L	NULL
)	NULL
site	NULL
or	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
©3	NULL
(	NULL
L	NULL
)	NULL
site	NULL
containing	NULL
the	NULL
3	NULL
'	NULL
mutation	NULL
.	NULL

Twenty-four	NULL
hours	NULL
later	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
mock	NULL
stimulated	NULL
(	NULL
Un	NULL
)	NULL
or	NULL
stimulated	NULL
with	NULL
P+I	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
,	NULL
and	NULL
the	NULL
percent	NULL
conversion	NULL
of	NULL
[	NULL
**CJchloramphenicol	NULL
to	NULL
its	NULL
acetylated	NULL
forms	NULL
was	NULL
quantified	NULL
with	NULL
a	NULL
Betagen	NULL
Betascope	NULL
.	NULL

The	NULL
results	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

In	NULL
both	NULL
A20	NULL
and	NULL
Ar-5	NULL
cells	NULL
,	NULL
the	NULL
patterns	NULL
of	NULL
expression	NULL
of	NULL
the	NULL
constructs	NULL
were	NULL
consistent	NULL
between	NULL
experiments	NULL
.	NULL

Standard	NULL
deviations	NULL
are	NULL
represented	NULL
by	NULL
the	NULL
error	NULL
bars	NULL
.	NULL

Within	NULL
each	NULL
experiment	NULL
,	NULL
the	NULL
results	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
-200	NULL
WT-induced	NULL
level	NULL
(	NULL
100	NULL
%	NULL
)	NULL
and	NULL
then	NULL
averaged	NULL
and	NULL
plotted	NULL
.	NULL

-117	NULL
to	NULL
-78	NULL
nt	NULL
relative	NULL
to	NULL
the	NULL
TNF-	NULL
«	NULL
cap	NULL
site	NULL
,	NULL
includes	NULL
the	NULL
intact	NULL
CRE	NULL
and	NULL
binds	NULL
to	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
as	NULL
well	NULL
as	NULL
two	NULL
molecules	NULL
of	NULL
NFATp	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
(	NULL
29	NULL
)	NULL
.	NULL

We	NULL
cloned	NULL
one	NULL
and	NULL
two	NULL
copies	NULL
of	NULL
this	NULL
oligonucleotide	NULL
upstream	NULL
of	NULL
a	NULL
truncated	NULL
TNF-	NULL
«	NULL
promoter	NULL
containing	NULL
only	NULL
-39	NULL
nt	NULL
relative	NULL
to	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
just	NULL
one	NULL
copy	NULL
of	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
'	NULL
is	NULL
inducible	NULL
and	NULL
two	NULL
copies	NULL
confer	NULL
dramatic	NULL
inducibility	NULL
upon	NULL
the	NULL
linked	NULL
promoter	NULL
,	NULL
almost	NULL
reaching	NULL
the	NULL
levels	NULL
achieved	NULL
with	NULL
the	NULL
intact	NULL
-200	NULL
TNF-	NULL
«	NULL
CAT	NULL
(	NULL
WT	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
and	NULL
reference	NULL
29	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
in	NULL
A20	NULL
cells	NULL
,	NULL
the	NULL
K3	NULL
(	NULL
L	NULL
)	NULL
*	NULL
construct	NULL
was	NULL
not	NULL
inducible	NULL
in	NULL
A20	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
,	NULL
and	NULL
two	NULL
copies	NULL
of	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
confer	NULL
only	NULL
modest	NULL
ionomycin	NULL
inducibility	NULL
upon	NULL
the	NULL
linked	NULL
truncated	NULL
-39	NULL
TNF-	NULL
«	NULL
promoter	NULL
,	NULL
which	NULL
is	NULL
approximately	NULL
15	NULL
%	NULL
of	NULL
the	NULL
levels	NULL
achieved	NULL
with	NULL
the	NULL
-200	NULL
TNF-	NULL
«	NULL
CAT	NULL
construct	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
A20	NULL
cells	NULL
,	NULL
an	NULL
intact	NULL
CRE	NULL
and	NULL
multiple	NULL
copies	NULL
of	NULL
x3	NULL
are	NULL
required	NULL
to	NULL
act	NULL
as	NULL
a	NULL
weak	NULL
inducible	NULL
enhancer	NULL
element	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
this	NULL
induction	NULL
requires	NULL
NFATp	NULL
,	NULL
we	NULL
cloned	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
oligonucleotide	NULL
bearing	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
3	NULL
'	NULL
aspect	NULL
of	NULL
x3	NULL
,	NULL
which	NULL
is	NULL
required	NULL
for	NULL
NFATp	NULL
binding	NULL
(	NULL
17	NULL
)	NULL
,	NULL
upstream	NULL
of	NULL
the	NULL
truncated	NULL
-39	NULL
TNF-	NULL
«	NULL
promoter	NULL
(	NULL
3	NULL
'M	NULL
)	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

6	NULL
,	NULL
this	NULL
mutation	NULL
abrogates	NULL
the	NULL
ability	NULL
of	NULL
the	NULL
oligonucleotide	NULL
to	NULL
act	NULL
as	NULL
an	NULL
inducible	NULL
enhancer	NULL
element	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

As	NULL
we	NULL
demonstrate	NULL
later	NULL
,	NULL
NFATp	NULL
binding	NULL
ac	NULL
tivity	NULL
is	NULL
lower	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
than	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
(	NULL
see	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
NFATp	NULL
is	NULL
recruited	NULL
to	NULL
the	NULL
x3	NULL
site	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
intact	NULL
promoter	NULL
because	NULL
of	NULL
its	NULL
relatively	NULL
high	NULL
abundance	NULL
in	NULL
this	NULL
cell	NULL
type	NULL
.	NULL

This	NULL
speculation	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
finding	NULL
that	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
xk3	NULL
(	NULL
L	NULL
)	NULL
is	NULL
sufficient	NULL
to	NULL
confer	NULL
inducibility	NULL
.	NULL

In	NULL
A20	NULL
B	NULL
cells	NULL
,	NULL
at	NULL
least	NULL
two	NULL
copies	NULL
of	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
are	NULL
required	NULL
for	NULL
the	NULL
minimal	NULL
inducibility	NULL
of	NULL
the	NULL
synthetic	NULL
promoter	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
lower	NULL
abundance	NULL
of	NULL
NFATp	NULL
,	NULL
which	NULL
is	NULL
apparently	NULL
not	NULL
sufficient	NULL
for	NULL
its	NULL
functional	NULL
association	NULL
with	NULL
the	NULL
x3	NULL
site	NULL
within	NULL
the	NULL
context	NULL
of	NULL
the	NULL
intact	NULL
promoter	NULL
in	NULL
A20	NULL
cells	NULL
.	NULL

The	NULL
TNF-a	NULL
@	NULL
promoter	NULL
contains	NULL
four	NULL
NFATp-binding	NULL
sites	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
there	NULL
were	NULL
other	NULL
,	NULL
as	NULL
of	NULL
yet	NULL
unrecognized	NULL
NFATp-binding	NULL
sites	NULL
in	NULL
the	NULL
TNF-	NULL
«	NULL
promoter	NULL
accounting	NULL
for	NULL
the	NULL
CsA-sensitive	NULL
inducibility	NULL
of	NULL
the	NULL
-200	NULL
TNF-a	NULL
CAT	NULL
construct	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
quantitative	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
using	NULL
recombinant	NULL
,	NULL
purified	NULL
NFATp	NULL
and	NULL
a	NULL
TNF-	NULL
«	NULL
promoter	NULL
fragment	NULL
spanning	NULL
from	NULL
-200	NULL
to	NULL
+87	NULL
nt	NULL
relative	NULL
to	NULL
the	NULL
cap	NULL
site	NULL
as	NULL
a	NULL
probe	NULL
.	NULL

Interestingly	NULL
,	NULL
we	NULL
identified	NULL
three	NULL
additional	NULL
NFATp-binding	NULL
sites	NULL
.	NULL

One	NULL
region	NULL
spanning	NULL
from	NULL
-104	NULL
to	NULL
-67	NULL
nt	NULL
,	NULL
which	NULL
includes	NULL
the	NULL
x3	NULL
element	NULL
as	NULL
well	NULL
as	NULL
another	NULL
pyrimidine-rich	NULL
region	NULL
centered	NULL
at	NULL
-76	NULL
nt	NULL
,	NULL
was	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
cleavage	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
there	NULL
are	NULL
two	NULL
other	NULL
regions	NULL
5238	NULL
TSAI	NULL
ET	NULL
AL	NULL
.	NULL

located	NULL
upstream	NULL
of	NULL
the	NULL
CRE	NULL
site	NULL
that	NULL
are	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
cleavage	NULL
centered	NULL
around	NULL
-117	NULL
and	NULL
-149	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
8	NULL
)	NULL
.	NULL

These	NULL
two	NULL
footprints	NULL
span	NULL
from	NULL
-121	NULL
to	NULL
-107	NULL
nt	NULL
relative	NULL
to	NULL
the	NULL
transcriptional	NULL
start	NULL
site	NULL
(	NULL
NFAT	NULL
-117	NULL
)	NULL
and	NULL
from	NULL
-165	NULL
to	NULL
-144	NULL
nt	NULL
(	NULL
NFAT	NULL
-149	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
.	NULL

The	NULL
novel	NULL
-76	NULL
NFATp-binding	NULL
element	NULL
is	NULL
required	NULL
for	NULL
TNF-a	NULL
«	NULL
@	NULL
gene	NULL
induction	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
and	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
introduced	NULL
mutations	NULL
into	NULL
the	NULL
NFAT	NULL
site	NULL
centered	NULL
at	NULL
-76	NULL
nt	NULL
to	NULL
determine	NULL
the	NULL
function	NULL
of	NULL
this	NULL
newly	NULL
discovered	NULL
NFAT	NULL
-binding	NULL
site	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
as	NULL
well	NULL
as	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

Constructs	NULL
bearing	NULL
mutations	NULL
in	NULL
the	NULL
core	NULL
of	NULL
the	NULL
site	NULL
,	NULL
76M	NULL
and	NULL
72M	NULL
(	NULL
bottom	NULL
of	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
,	NULL
were	NULL
tested	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
and	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

In	NULL
both	NULL
cell	NULL
types	NULL
,	NULL
the	NULL
promoter	NULL
's	NULL
inducibility	NULL
was	NULL
severely	NULL
affected	NULL
by	NULL
these	NULL
mutations	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
mutations	NULL
in	NULL
the	NULL
sequences	NULL
flanking	NULL
the	NULL
core	NULL
of	NULL
the	NULL
site	NULL
(	NULL
SOM	NULL
,	NULL
68M	NULL
,	NULL
and	NULL
59M	NULL
)	NULL
also	NULL
slightly	NULL
decreased	NULL
inducibility	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

Deletion	NULL
of	NULL
the	NULL
sequences	NULL
between	NULL
-200	NULL
and	NULL
-142	NULL
nt	NULL
relative	NULL
to	NULL
the	NULL
TNF-a	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
which	NULL
deletes	NULL
the	NULL
most	NULL
upstream	NULL
NFAT	NULL
site	NULL
,	NULL
decreases	NULL
absolute	NULL
levels	NULL
of	NULL
CAT	NULL
activity	NULL
but	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
the	NULL
promoter	NULL
's	NULL
inducibility	NULL
in	NULL
A20	NULL
cells	NULL
or	NULL
Ar-5	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
and	NULL
reference	NULL
29	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
in	NULL
Fig	NULL
.	NULL

2	NULL
,	NULL
a	NULL
mutation	NULL
in	NULL
the	NULL
core	NULL
of	NULL
the	NULL
-117	NULL
site	NULL
has	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
inducibility	NULL
of	NULL
the	NULL
TNF-a	NULL
gene	NULL
in	NULL
A20	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
,	NULL
although	NULL
this	NULL
same	NULL
mutation	NULL
decreases	NULL
gene	NULL
induction	NULL
in	NULL
T	NULL
cells	NULL
to	NULL
approximately	NULL
50	NULL
%	NULL
of	NULL
wild-type	NULL
levels	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
only	NULL
the	NULL
NFAT	NULL
site	NULL
that	NULL
is	NULL
centered	NULL
at	NULL
-76	NULL
,	NULL
and	NULL
not	NULL
the	NULL
NFAT	NULL
site	NULL
centered	NULL
at	NULL
-149	NULL
or	NULL
-117	NULL
,	NULL
is	NULL
required	NULL
for	NULL
induction	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

We	NULL
note	NULL
that	NULL
the	NULL
same	NULL
pattern	NULL
of	NULL
expression	NULL
for	NULL
all	NULL
of	NULL
the	NULL
mutant	NULL
constructs	NULL
displayed	NULL
in	NULL
Fig	NULL
.	NULL

8	NULL
was	NULL
obtained	NULL
when	NULL
ionomycin	NULL
alone	NULL
was	NULL
used	NULL
as	NULL
the	NULL
inducer	NULL
in	NULL
A20	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

To	NULL
test	NULL
whether	NULL
NFATp	NULL
present	NULL
in	NULL
A20	NULL
and	NULL
Ar-5	NULL
nuclear	NULL
extracts	NULL
was	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
the	NULL
-76	NULL
NFAT	NULL
site	NULL
,	NULL
we	NULL
constructed	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
spanning	NULL
the	NULL
region	NULL
from	NULL
-85	NULL
to	NULL
-59	NULL
nt	NULL
and	NULL
performed	NULL
an	NULL
EMSA	NULL
using	NULL
nuclear	NULL
extracts	NULL
from	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

The	NULL
-85	NULL
to	NULL
-59	NULL
nt	NULL
probe	NULL
formed	NULL
a	NULL
single	NULL
complex	NULL
in	NULL
uninduced	NULL
Ar-5	NULL
and	NULL
A20	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

9A	NULL
,	NULL
lanes	NULL
1	NULL
and	NULL
7	NULL
,	NULL
respectively	NULL
)	NULL
,	NULL
which	NULL
was	NULL
inducible	NULL
by	NULL
ionomycin	NULL
(	NULL
lanes	NULL
2	NULL
and	NULL
8	NULL
)	NULL
and	NULL
was	NULL
CsA	NULL
sensitive	NULL
(	NULL
lanes	NULL
3	NULL
and	NULL
9	NULL
)	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
mutation	NULL
carried	NULL
in	NULL
the	NULL
76M	NULL
construct	NULL
that	NULL
decreased	NULL
reporter	NULL
gene	NULL
activity	NULL
in	NULL
the	NULL
transfection	NULL
assays	NULL
would	NULL
also	NULL
have	NULL
an	NULL
effect	NULL
on	NULL
the	NULL
binding	NULL
of	NULL
this	NULL
protein	NULL
complex	NULL
in	NULL
vitro	NULL
,	NULL
we	NULL
incorporated	NULL
the	NULL
76M	NULL
mutation	NULL
into	NULL
the	NULL
-85	NULL
to	NULL
-=59	NULL
nt	NULL
oligonucleotide	NULL
probe	NULL
(	NULL
bottom	NULL
of	NULL
Fig	NULL
.	NULL

9A	NULL
)	NULL
.	NULL

This	NULL
mutant	NULL
probe	NULL
was	NULL
incapable	NULL
of	NULL
forming	NULL
any	NULL
complex	NULL
in	NULL
unin-duced	NULL
,	NULL
ionomycin-induced	NULL
,	NULL
and	NULL
CsA-pretreated	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
Ar-5	NULL
(	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
)	NULL
or	NULL
A20	NULL
(	NULL
lanes	NULL
10	NULL
to	NULL
12	NULL
)	NULL
cells	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
same	NULL
mutation	NULL
that	NULL
decreased	NULL
CAT	NULL
activity	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
in	NULL
vivo	NULL
also	NULL
abrogated	NULL
binding	NULL
in	NULL
vitro	NULL
.	NULL

The	NULL
identity	NULL
of	NULL
this	NULL
complex	NULL
was	NULL
determined	NULL
by	NULL
using	NULL
an	NULL
antibody	NULL
to	NULL
NFATp	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

9B	NULL
,	NULL
the	NULL
antibody	NULL
to	NULL
NFATp	NULL
recognizes	NULL
the	NULL
complex	NULL
in	NULL
both	NULL
B-	NULL
and	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
complex	NULL
binding	NULL
to	NULL
the	NULL
-85	NULL
to	NULL
-59	NULL
nt	NULL
probe	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
corresponds	NULL
to	NULL
NFATp	NULL
or	NULL
an	NULL
antigenically	NULL
related	NULL
protein	NULL
.	NULL

Interestingly	NULL
,	NULL
with	NULL
the	NULL
same	NULL
amount	NULL
of	NULL
nuclear	NULL
extract	NULL
,	NULL
NFATp	NULL
binding	NULL
is	NULL
stronger	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
than	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
with	NULL
lanes	NULL
7	NULL
to	NULL
9	NULL
in	NULL
Fig	NULL
.	NULL

8A	NULL
and	NULL
lanes	NULL
2	NULL
to	NULL
4	NULL
in	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
higher	NULL
concentration	NULL
of	NULL
NFATp	NULL
in	NULL
Ar-5	NULL
cells	NULL
than	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
demonstrate	NULL
a	NULL
critical	NULL
role	NULL
for	NULL
NFATp	NULL
binding	NULL
to	NULL
the	NULL
-76	NULL
NFAT	NULL
site	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
in	NULL
both	NULL
A20	NULL
B	NULL
cells	NULL
and	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

Our	NULL
EMSA	NULL
experiments	NULL
using	NULL
nuclear	NULL
extracts	NULL
suggested	NULL
that	NULL
the	NULL
-76	NULL
site	NULL
binds	NULL
NFATp	NULL
with	NULL
a	NULL
higher	NULL
affinity	NULL
than	NULL
the	NULL
x3	NULL
site	NULL
.	NULL

To	NULL
confirm	NULL
this	NULL
observation	NULL
,	NULL
we	NULL
examined	NULL
our	NULL
quantitative	NULL
DNase	NULL
I	NULL
footprinting	NULL
experiment	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

7A	NULL
.	NULL

The	NULL
Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

nucleotides	NULL
centered	NULL
around	NULL
-76	NULL
(	NULL
NFAT	NULL
-76	NULL
)	NULL
and	NULL
spanning	NULL
from	NULL
-84	NULL
to	NULL
-67	NULL
nt	NULL
were	NULL
protected	NULL
from	NULL
DNase	NULL
I	NULL
cleavage	NULL
at	NULL
the	NULL
lowest	NULL
concentrations	NULL
of	NULL
NFATp	NULL
(	NULL
Fig	NULL
.	NULL

6A	NULL
,	NULL
lanes	NULL
3	NULL
to	NULL
8	NULL
)	NULL
,	NULL
whereas	NULL
the	NULL
footprint	NULL
centered	NULL
around	NULL
the	NULL
x3	NULL
site	NULL
(	NULL
from	NULL
-104	NULL
to	NULL
-84	NULL
nt	NULL
)	NULL
appeared	NULL
at	NULL
intermediate	NULL
concentrations	NULL
of	NULL
recombinant	NULL
protein	NULL
(	NULL
lanes	NULL
5	NULL
to	NULL
8	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
EMSA	NULL
data	NULL
,	NULL
which	NULL
demonstrate	NULL
that	NULL
in	NULL
A20	NULL
nuclear	NULL
extracts	NULL
the	NULL
-76	NULL
site	NULL
binds	NULL
to	NULL
NFATp	NULL
(	NULL
Fig	NULL
.	NULL

9B	NULL
)	NULL
whereas	NULL
the	NULL
x3	NULL
site	NULL
does	NULL
not	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
,	NULL
the	NULL
NFAT-76	NULL
site	NULL
had	NULL
a	NULL
higher	NULL
binding	NULL
affinity	NULL
for	NULL
recombinant	NULL
NFAT	NULL
p	NULL
than	NULL
the	NULL
x3	NULL
site	NULL
.	NULL

ATF-2-Jun	NULL
and	NULL
NFAT	NULL
p	NULL
do	NULL
not	NULL
bind	NULL
cooperatively	NULL
.	NULL

We	NULL
have	NULL
previously	NULL
shown	NULL
that	NULL
NFATp	NULL
and	NULL
ATF-2-Jun	NULL
do	NULL
not	NULL
cooperatively	NULL
bind	NULL
to	NULL
the	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
site	NULL
in	NULL
an	NULL
EMSA	NULL
(	NULL
29	NULL
)	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
the	NULL
multiple	NULL
other	NULL
NFAT	NULL
sites	NULL
in	NULL
the	NULL
TNF-	NULL
«	NULL
promoter	NULL
could	NULL
bind	NULL
ATF-2-Jun	NULL
and	NULL
NFATp	NULL
cooperatively	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
quantitative	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
using	NULL
increasing	NULL
amounts	NULL
of	NULL
NFATp	NULL
in	NULL
the	NULL
absence	NULL
or	NULL
presence	NULL
of	NULL
a	NULL
fixed	NULL
amount	NULL
of	NULL
ATF-2-Jun	NULL
.	NULL

Binding	NULL
of	NULL
recombinant	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
to	NULL
the	NULL
TNF-a	NULL
promoter	NULL
resulted	NULL
in	NULL
the	NULL
protection	NULL
from	NULL
DNase	NULL
I	NULL
cleavage	NULL
of	NULL
a	NULL
region	NULL
centered	NULL
around	NULL
the	NULL
CRE	NULL
site	NULL
spanning	NULL
from	NULL
-112	NULL
to	NULL
-92	NULL
nt	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
,	NULL
lane	NULL
2	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
affinity	NULL
of	NULL
NFATp	NULL
for	NULL
any	NULL
of	NULL
the	NULL
TNF-a	NULL
«	NULL
NFAT	NULL
-binding	NULL
sites	NULL
is	NULL
not	NULL
changed	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
ATF-2	NULL
and	NULL
Jun	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
to	NULL
8	NULL
to	NULL
9	NULL
to	NULL
14	NULL
in	NULL
Fig	NULL
.	NULL

6A	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
ATF-2-Jun	NULL
and	NULL
NFATp	NULL
do	NULL
not	NULL
cooperatively	NULL
bind	NULL
on	NULL
the	NULL
TNF-a	NULL
promoter	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
previous	NULL
EMSA	NULL
analyses	NULL
(	NULL
29	NULL
)	NULL
.	NULL

NFATp	NULL
does	NULL
not	NULL
bind	NULL
cooperatively	NULL
to	NULL
the	NULL
TNF-	NULL
«	NULL
@	NULL
NFAT	NULL
sites	NULL
.	NULL

To	NULL
examine	NULL
whether	NULL
NFATp	NULL
binds	NULL
cooperatively	NULL
to	NULL
the	NULL
multiple	NULL
NFAT	NULL
sites	NULL
in	NULL
the	NULL
TNF-a	NULL
promoter	NULL
,	NULL
we	NULL
performed	NULL
a	NULL
quantitative	NULL
DNase	NULL
I	NULL
analysis	NULL
on	NULL
different	NULL
DNA	NULL
templates	NULL
bearing	NULL
mutations	NULL
in	NULL
the	NULL
-76	NULL
(	NULL
-76M	NULL
)	NULL
and	NULL
3	NULL
(	NULL
5	NULL
'M	NULL
and	NULL
3	NULL
'M	NULL
)	NULL
sites	NULL
and	NULL
compared	NULL
their	NULL
abilities	NULL
to	NULL
bind	NULL
NFATp	NULL
to	NULL
a	NULL
WT	NULL
DNA	NULL
template	NULL
.	NULL

These	NULL
templates	NULL
were	NULL
identical	NULL
to	NULL
those	NULL
promoter	NULL
fragments	NULL
(	NULL
WT	NULL
,	NULL
76M	NULL
,	NULL
5	NULL
,	NULL
and	NULL
3	NULL
'	NULL
)	NULL
used	NULL
in	NULL
the	NULL
transfection	NULL
assays	NULL
(	NULL
Figs	NULL
2	NULL
and	NULL
8	NULL
)	NULL
.	NULL

As	NULL
demonstrated	NULL
in	NULL
Fig	NULL
.	NULL

10A	NULL
,	NULL
the	NULL
-76	NULL
mutation	NULL
abrogates	NULL
binding	NULL
of	NULL
recombinant	NULL
NFATp	NULL
to	NULL
the	NULL
-76	NULL
site	NULL
without	NULL
disturbing	NULL
NFATp	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
3	NULL
site	NULL
(	NULL
compare	NULL
lanes	NULL
2	NULL
to	NULL
6	NULL
with	NULL
lanes	NULL
16	NULL
to	NULL
20	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
there	NULL
is	NULL
no	NULL
cooperative	NULL
binding	NULL
between	NULL
the	NULL
x3	NULL
and	NULL
the	NULL
-76	NULL
NFAT	NULL
sites	NULL
.	NULL

As	NULL
expected	NULL
,	NULL
consistent	NULL
with	NULL
the	NULL
EMSA	NULL
analysis	NULL
,	NULL
the	NULL
-76	NULL
mutation	NULL
abolishes	NULL
the	NULL
binding	NULL
of	NULL
NFATp	NULL
to	NULL
the	NULL
-76	NULL
site	NULL
;	NULL
however	NULL
,	NULL
the	NULL
affinity	NULL
of	NULL
NFATp	NULL
for	NULL
all	NULL
of	NULL
the	NULL
other	NULL
sites	NULL
is	NULL
not	NULL
affected	NULL
(	NULL
lanes	NULL
16	NULL
to	NULL
20	NULL
)	NULL
.	NULL

As	NULL
a	NULL
negative	NULL
control	NULL
,	NULL
we	NULL
demonstrated	NULL
that	NULL
ATF-2-Jun	NULL
binds	NULL
to	NULL
the	NULL
-76M	NULL
probe	NULL
with	NULL
similar	NULL
affinity	NULL
as	NULL
it	NULL
does	NULL
to	NULL
the	NULL
WT	NULL
probe	NULL
(	NULL
compare	NULL
lanes	NULL
11	NULL
to	NULL
14	NULL
with	NULL
lanes	NULL
25	NULL
to	NULL
28	NULL
)	NULL
.	NULL

To	NULL
delineate	NULL
further	NULL
any	NULL
potential	NULL
cooperative	NULL
interactions	NULL
between	NULL
the	NULL
TNF-	NULL
«	NULL
NFAT	NULL
-binding	NULL
sites	NULL
,	NULL
we	NULL
used	NULL
DNA	NULL
templates	NULL
bearing	NULL
mutations	NULL
in	NULL
the	NULL
5	NULL
'	NULL
or	NULL
3	NULL
'	NULL
subsite	NULL
of	NULL
x3	NULL
in	NULL
quantitative	NULL
DNase	NULL
I	NULL
analyses	NULL
.	NULL

Increasing	NULL
amounts	NULL
of	NULL
recombinant	NULL
NFATp	NULL
are	NULL
able	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
5M	NULL
probe	NULL
with	NULL
almost	NULL
the	NULL
same	NULL
affinity	NULL
as	NULL
to	NULL
the	NULL
WT	NULL
promoter	NULL
(	NULL
Fig	NULL
.	NULL

10A	NULL
,	NULL
lanes	NULL
30	NULL
to	NULL
34	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
3	NULL
'M	NULL
probe	NULL
is	NULL
unable	NULL
to	NULL
bind	NULL
NFAT	NULL
p	NULL
at	NULL
the	NULL
x3	NULL
site	NULL
(	NULL
lanes	NULL
39	NULL
to	NULL
44	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
a	NULL
previous	NULL
EMSA	NULL
analysis	NULL
.	NULL

Given	NULL
that	NULL
the	NULL
x3	NULL
site	NULL
resembles	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
consensus	NULL
se-quence	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
ability	NULL
of	NULL
p50-p65	NULL
heterodimers	NULL
to	NULL
bind	NULL
to	NULL
the	NULL
WT	NULL
DNA	NULL
template	NULL
in	NULL
the	NULL
quantitative	NULL
DNase	NULL
hypersensitivity	NULL
assay	NULL
.	NULL

Recombinant	NULL
NF-kB	NULL
proteins	NULL
do	NULL
not	NULL
recognize	NULL
any	NULL
of	NULL
the	NULL
sequences	NULL
in	NULL
the	NULL
TNF-	NULL
«	NULL
promoter	NULL
shown	NULL
to	NULL
be	NULL
functionally	NULL
important	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
gene	NULL
(	NULL
Fig	NULL
.	NULL

10A	NULL
,	NULL
lanes	NULL
7	NULL
to	NULL
10	NULL
)	NULL
.	NULL

These	NULL
results	NULL
support	NULL
previous	NULL
functional	NULL
analyses	NULL
(	NULL
6	NULL
,	NULL
9	NULL
)	NULL
demonstrating	NULL
that	NULL
NF-kB	NULL
proteins	NULL
do	NULL
not	NULL
play	NULL
a	NULL
significant	NULL
role	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
human	NULL
TNF-	NULL
«	NULL
gene	NULL
(	NULL
6	NULL
,	NULL
9	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Binding	NULL
of	NULL
NFATp	NULL
to	NULL
the	NULL
sites	NULL
centered	NULL
at	NULL
-76	NULL
,	NULL
-117	NULL
,	NULL
and	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
A.	NULL
CELL-TYPE-SPECIFIC	NULL
REGULATION	NULL
OF	NULL
THE	NULL
HUMAN	NULL
TNF-	NULL
«	NULL
GENE	NULL
Probe	NULL
_	NULL
=	NULL
--	NULL
--	NULL
--	NULL
WT	NULL
--	NULL
--	NULL
-	NULL
NFATp	NULL
ATF-2/Jun	NULL
1	NULL
2	NULL
3	NULL
4	NULL
5	NULL
6	NULL
7	NULL
8	NULL
u-	NULL
-	NULL
]	NULL
tot	NULL
+	NULL
+	NULL
+	NULL
+	NULL
9	NULL
10	NULL
11121314	NULL
L	NULL
LI	NULL
I	NULL
#	NULL
«	NULL
=	NULL
SR	NULL
s	NULL
-104-	NULL
#	NULL
#	NULL
8	NULL
»	NULL
P	NULL
~112-®	NULL
**	NULL
Genes	NULL
-121-	NULL
“	NULL
F	NULL
:	NULL
=~=	NULL
#	NULL
pt	NULL
us	NULL
£42	NULL
-	NULL
28	NULL
F	NULL
«	NULL
*a	NULL
--	NULL
_	NULL
“	NULL
Bis	NULL
:	NULL
og	NULL
:	NULL
:	NULL
.14	NULL
,	NULL
-	NULL
=	NULL
-	NULL
jetta	NULL
165	NULL
-	NULL
rTe	NULL
cme	NULL
:	NULL
B.	NULL
NFAT	NULL
-149	NULL
165	NULL
``	NULL
144	NULL
5°	NULL
CCCGCGATGGAGAAGAAACCGAG	NULL
3	NULL
GGGCGCTACCTCTICTIIGGCTC	NULL
NFAT	NULL
~117	NULL
421	NULL
5°	NULL
ACCGCTTCCTCCAGA	NULL
3°	NULL
TGGCGAAGGAGGTCA	NULL
NFAT	NULL
x3	NULL
4104	NULL
44	NULL
5	NULL
'	NULL
AGCTCATGGGTTTCTCCA	NULL
3	NULL
'	NULL
TCGAGTACCGAAAGAGGT	NULL
NFAT	NULL
-76	NULL
44	NULL
47	NULL
5	NULL
'	NULL
AAGGAAGIITIICCGCTGG	NULL
3	NULL
'	NULL
TTCCTTCAAAAGGCGACC	NULL
ATF-Z/JUNCRE	NULL
2	NULL
5	NULL
TCCAGATGJAGCTCATGGGTTTS	NULL
AGGTCTACTCGAGTACCCAAA	NULL
nearks	NULL
_	NULL
[	NULL
NF	NULL
NFAT	NULL
-117	NULL
NFAT	NULL
-149	NULL
ATF-2/Jun-CRE	NULL
5239	NULL
-149	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
either	NULL
the	NULL
5	NULL
'M	NULL
or	NULL
the	NULL
3	NULL
'M	NULL
«	NULL
3	NULL
mutation	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
to	NULL
6	NULL
to	NULL
lanes	NULL
29	NULL
to	NULL
34	NULL
and	NULL
39	NULL
to	NULL
44	NULL
in	NULL
Fig	NULL
.	NULL

10A	NULL
)	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
5	NULL
mutation	NULL
,	NULL
which	NULL
is	NULL
immediately	NULL
downstream	NULL
of	NULL
the	NULL
CRE	NULL
,	NULL
severely	NULL
compromises	NULL
ATF-2-Jun	NULL
binding	NULL
(	NULL
compare	NULL
lanes	NULL
11	NULL
to	NULL
14	NULL
with	NULL
lanes	NULL
35	NULL
to	NULL
38	NULL
)	NULL
.	NULL

These	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
our	NULL
EMSA	NULL
data	NULL
showing	NULL
that	NULL
an	NULL
oligonucleotide	NULL
probe	NULL
bearing	NULL
the	NULL
5	NULL
'	NULL
mutation	NULL
was	NULL
severely	NULL
compromised	NULL
in	NULL
its	NULL
ability	NULL
to	NULL
form	NULL
the	NULL
major	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
CRE-binding	NULL
complex	NULL
in	NULL
A20	NULL
nuclear	NULL
extracts	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

However	NULL
,	NULL
although	NULL
the	NULL
5M	NULL
probe	NULL
binds	NULL
ATF-2/Jun	NULL
with	NULL
lower	NULL
affinity	NULL
than	NULL
does	NULL
the	NULL
WT	NULL
probe	NULL
,	NULL
both	NULL
NFATp	NULL
and	NULL
ATF-2	NULL
can	NULL
still	NULL
occupy	NULL
their	NULL
binding	NULL
sites	NULL
simultaneously	NULL
on	NULL
the	NULL
5	NULL
'	NULL
mutant	NULL
probe	NULL
(	NULL
compare	NULL
lanes	NULL
1	NULL
to	NULL
11	NULL
with	NULL
lanes	NULL
12	NULL
to	NULL
17	NULL
in	NULL
Fig	NULL
.	NULL

10B	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
fact	NULL
that	NULL
the	NULL
5	NULL
'	NULL
x3	NULL
mutation	NULL
decreases	NULL
TNF-	NULL
«	NULL
gene	NULL
expression	NULL
is	NULL
not	NULL
due	NULL
to	NULL
interference	NULL
with	NULL
NFATp	NULL
binding	NULL
but	NULL
rather	NULL
is	NULL
due	NULL
to	NULL
a	NULL
decrease	NULL
in	NULL
ATF-2-Jun	NULL
binding	NULL
.	NULL

DISCUSSION	NULL
The	NULL
TNF-	NULL
«	NULL
gene	NULL
provides	NULL
a	NULL
unique	NULL
opportunity	NULL
to	NULL
study	NULL
how	NULL
complex	NULL
patterns	NULL
of	NULL
gene	NULL
expression	NULL
are	NULL
established	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
show	NULL
that	NULL
a	NULL
single	NULL
TNF-	NULL
«	NULL
regulatory	NULL
element	NULL
,	NULL
the	NULL
x3	NULL
site	NULL
,	NULL
is	NULL
differentially	NULL
used	NULL
in	NULL
two	NULL
cell	NULL
types	NULL
in	NULL
response	NULL
to	NULL
the	NULL
same	NULL
extracellular	NULL
signal	NULL
.	NULL

Stimulation	NULL
of	NULL
both	NULL
B	NULL
cells	NULL
and	NULL
T	NULL
cells	NULL
with	NULL
calcium	NULL
ionophore	NULL
results	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
TNF-a	NULL
gene	NULL
transcription	NULL
,	NULL
and	NULL
the	NULL
treatment	NULL
of	NULL
either	NULL
cell	NULL
type	NULL
with	NULL
CsA	NULL
or	NULL
FK506	NULL
prior	NULL
to	NULL
cellular	NULL
activation	NULL
blocks	NULL
gene	NULL
expres-sion	NULL
.	NULL

In	NULL
this	NULL
report	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
that	NULL
depending	NULL
on	NULL
the	NULL
particular	NULL
cellular	NULL
milieu	NULL
in	NULL
which	NULL
the	NULL
TNF-	NULL
«	NULL
promoter	NULL
func-tions	NULL
,	NULL
the	NULL
composite	NULL
k3/CRE	NULL
site	NULL
differentially	NULL
associates	NULL
with	NULL
NFATp	NULL
and	NULL
with	NULL
ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
after	NULL
cellular	NULL
stimulation	NULL
.	NULL

The	NULL
«	NULL
3	NULL
site	NULL
does	NULL
not	NULL
bind	NULL
NFATp	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
it	NULL
does	NULL
bind	NULL
two	NULL
molecules	NULL
of	NULL
NFATp	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
CRE	NULL
is	NULL
recognized	NULL
by	NULL
an	NULL
ATF-2-Jun	NULL
heterodimer	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

In	NULL
A20	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
promoter	NULL
requires	NULL
a	NULL
previously	NULL
unrecognized	NULL
NFAT	NULL
-binding	NULL
site	NULL
centered	NULL
at	NULL
-76	NULL
nt	NULL
.	NULL

The	NULL
-76	NULL
NFAT	NULL
site	NULL
also	NULL
plays	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

Furthermore	NULL
,	NULL
we	NULL
have	NULL
identified	NULL
two	NULL
other	NULL
previously	NULL
unrecognized	NULL
NFAT-binding	NULL
sites	NULL
.	NULL

The	NULL
site	NULL
centered	NULL
at	NULL
-117	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
minor	NULL
role	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
but	NULL
does	NULL
not	NULL
appear	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
gene	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

The	NULL
most	NULL
upstream	NULL
site	NULL
centered	NULL
at	NULL
-149	NULL
appears	NULL
to	NULL
play	NULL
a	NULL
minimal	NULL
role	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
functional	NULL
binding	NULL
of	NULL
NFATp	NULL
to	NULL
sites	NULL
in	NULL
the	NULL
TNF-a	NULL
promoter	NULL
is	NULL
cell	NULL
type	NULL
specific	NULL
.	NULL

Our	NULL
finding	NULL
that	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
NFATp	NULL
binding	NULL
to	NULL
the	NULL
x3	NULL
element	NULL
is	NULL
not	NULL
required	NULL
in	NULL
the	NULL
context	NULL
of	NULL
the	NULL
intact	NULL
TNF-	NULL
«	NULL
promoter	NULL
but	NULL
is	NULL
required	NULL
for	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
synthetic	NULL
homopolymeric	NULL
promoter	NULL
is	NULL
intriguing	NULL
.	NULL

Our	NULL
footprinting	NULL
data	NULL
obtained	NULL
in	NULL
assays	NULL
using	NULL
recombinant	NULL
purified	NULL
proteins	NULL
demonstrate	NULL
that	NULL
the	NULL
x3	NULL
site	NULL
binds	NULL
NFATp	NULL
with	NULL
lower	NULL
affinity	NULL
than	NULL
the	NULL
newly	NULL
identified	NULL
-76	NULL
NFAT	NULL
site	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
have	NULL
shown	NULL
FIG	NULL
.	NULL

7	NULL
.	NULL

There	NULL
are	NULL
multiple	NULL
NFATp-binding	NULL
sites	NULL
in	NULL
the	NULL
TNF-a	NULL
promoter	NULL
,	NULL
and	NULL
there	NULL
is	NULL
no	NULL
evidence	NULL
of	NULL
cooperative	NULL
binding	NULL
between	NULL
NFATp	NULL
and	NULL
ATF-2-Jun	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Quantitative	NULL
DNase	NULL
I	NULL
hypersensitivity	NULL
assay	NULL
using	NULL
a	NULL
TNF-a	NULL
promoter	NULL
fragment	NULL
spanning	NULL
the	NULL
sequences	NULL
from	NULL
-200	NULL
to	NULL
+87	NULL
(	NULL
WT	NULL
)	NULL
.	NULL

The	NULL
DNA	NULL
template	NULL
was	NULL
end	NULL
labeled	NULL
(	NULL
20,000	NULL
cpm	NULL
)	NULL
at	NULL
the	NULL
noncoding	NULL
strand	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
indicated	NULL
proteins	NULL
.	NULL

The	NULL
concentration	NULL
of	NULL
ATF-2-Jun	NULL
added	NULL
was	NULL
300	NULL
ng	NULL
,	NULL
and	NULL
NFATp	NULL
was	NULL
added	NULL
in	NULL
increasing	NULL
concentrations	NULL
at	NULL
1	NULL
,	NULL
3	NULL
,	NULL
10	NULL
,	NULL
30	NULL
,	NULL
100	NULL
,	NULL
and	NULL
300	NULL
ng	NULL
,	NULL
as	NULL
indicated	NULL
by	NULL
the	NULL
wedges	NULL
.	NULL

(	NULL
B	NULL
)	NULL
TNF-	NULL
«	NULL
promoter	NULL
sequences	NULL
forming	NULL
footprints	NULL
with	NULL
the	NULL
recombinant	NULL
NFATp	NULL
or	NULL
ATF-2-Jun	NULL
proteins	NULL
in	NULL
the	NULL
DNase	NULL
I	NULL
footprinting	NULL
analysis	NULL
displayed	NULL
panel	NULL
A	NULL
.	NULL

The	NULL
pyrimidine-rich	NULL
core	NULL
sequences	NULL
of	NULL
the	NULL
NFAT-binding	NULL
sites	NULL
are	NULL
underlined	NULL
,	NULL
as	NULL
is	NULL
the	NULL
CRE	NULL
motif	NULL
within	NULL
the	NULL
ATF-2-Jun	NULL
foot-print	NULL
.	NULL

A20	NULL
B	NULL
Cells	NULL
.	NULL

Un	NULL
El	NULL
P+I	NULL
.	NULL

PH/CS=A	NULL
140	NULL
120	NULL
=	NULL
100	NULL
G	NULL
.	NULL
'	NULL

_	NULL
.	NULL

e	NULL
80	NULL
C	NULL
3	NULL
at-=	NULL
&	NULL
40	NULL
20	NULL
0	NULL
~	NULL
P	NULL
WT	NULL
8C	NULL
76	NULL
72	NULL
68	NULL
59	NULL
55	NULL
45	NULL
41	NULL
37	NULL
Mutation	NULL
Ar-5	NULL
T	NULL
Cells	NULL
.	NULL

Un	NULL
D	NULL
long	NULL
l	NULL
lono/CsA	NULL
4	NULL
<	NULL
L	NULL
.	NULL

hal	NULL
WJ	NULL
y	NULL
©	NULL
3	NULL
WT	NULL
80	NULL
76	NULL
72	NULL
bR	NULL
59	NULL
55	NULL
45	NULL
41	NULL
37	NULL
Mutation	NULL
+80	NULL
-70	NULL
AP-1-s0	NULL
-50	NULL
SP-1	NULL
40	NULL
AP-2	NULL
+340	NULL
AagttrrcocTestIGaaTGaTTCTTTCCECGCCCTCCTETCGCCCCAGGGACAT	NULL
AT	NULL
AA	NULL
#	NULL
som	NULL
CTco	NULL
.	NULL

=	NULL
:	NULL
7	NULL
BM	NULL
CACT	NULL
7	NULL
2M	NULL
ATTA	NULL
6BM	NULL
ATTA	NULL
59M	NULL
CGCG	NULL
55M	NULL
AGAT	NULL
45M	NULL
GATA	NULL
41	NULL
M	NULL
GAAT	NULL
37M	NULL
ATTA	NULL
FIG	NULL
.	NULL

8	NULL
.	NULL

Further	NULL
characterization	NULL
of	NULL
sequences	NULL
contributing	NULL
to	NULL
TNF-	NULL
«	NULL
promoter	NULL
activity	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
and	NULL
Ar-5	NULL
T	NULL
cells	NULL
:	NULL
identification	NULL
of	NULL
a	NULL
novel	NULL
NFATp-binding	NULL
site	NULL
.	NULL

A20	NULL
B	NULL
cells	NULL
or	NULL
Ar-5	NULL
T	NULL
cells	NULL
were	NULL
transfected	NULL
with	NULL
the	NULL
WT	NULL
(	NULL
-200	NULL
TNF-a	NULL
promoter	NULL
)	NULL
CAT	NULL
construct	NULL
and	NULL
mutated	NULL
TNF-a	NULL
promoter	NULL
CAT	NULL
plasmids	NULL
displayed	NULL
at	NULL
the	NULL
bottom	NULL
and	NULL
24	NULL
h	NULL
later	NULL
were	NULL
mock	NULL
stimulated	NULL
(	NULL
Un	NULL
)	NULL
or	NULL
induced	NULL
with	NULL
P+1	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
.	NULL

CAT	NULL
assays	NULL
were	NULL
performed	NULL
,	NULL
and	NULL
the	NULL
percent	NULL
conversion	NULL
of	NULL
[	NULL
'*CJchloramphenicol	NULL
to	NULL
its	NULL
acetylated	NULL
forms	NULL
was	NULL
quantified	NULL
with	NULL
a	NULL
Betagen	NULL
Betascope	NULL
.	NULL

Within	NULL
each	NULL
experiment	NULL
,	NULL
the	NULL
results	NULL
were	NULL
normalized	NULL
to	NULL
the	NULL
-199	NULL
WT-induced	NULL
level	NULL
(	NULL
100	NULL
%	NULL
)	NULL
and	NULL
then	NULL
averaged	NULL
and	NULL
plotted	NULL
.	NULL

Standard	NULL
deviations	NULL
are	NULL
represented	NULL
by	NULL
the	NULL
error	NULL
bars	NULL
.	NULL

The	NULL
results	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
are	NULL
shown	NULL
.	NULL

The	NULL
average	NULL
values	NULL
for	NULL
fold	NULL
induction	NULL
for	NULL
the	NULL
various	NULL
constructs	NULL
in	NULL
the	NULL
A20	NULL
cells	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
WT	NULL
,	NULL
15.9	NULL
;	NULL
-80	NULL
,	NULL
5.7	NULL
;	NULL
-76	NULL
,	NULL
4.8	NULL
;	NULL
-72	NULL
,	NULL
3.9	NULL
;	NULL
-68	NULL
,	NULL
8.0	NULL
;	NULL
-59	NULL
,	NULL
9.7	NULL
;	NULL
-55	NULL
,	NULL
18.8	NULL
;	NULL
-45	NULL
,	NULL
10.1	NULL
;	NULL
-41	NULL
,	NULL
12.1	NULL
;	NULL
and	NULL
-37	NULL
,	NULL
10.5	NULL
.	NULL

The	NULL
average	NULL
values	NULL
for	NULL
fold	NULL
induction	NULL
for	NULL
the	NULL
various	NULL
constructs	NULL
in	NULL
the	NULL
Ar-5	NULL
T	NULL
cells	NULL
are	NULL
as	NULL
follows	NULL
:	NULL
WT	NULL
,	NULL
11.3	NULL
;	NULL
-80	NULL
,	NULL
7.0	NULL
;	NULL
-76	NULL
,	NULL
4.7	NULL
;	NULL
-72	NULL
,	NULL
4	NULL
;	NULL
-68	NULL
,	NULL
9.5	NULL
;	NULL
-59	NULL
,	NULL
8.9	NULL
;	NULL
-55	NULL
,	NULL
5.9	NULL
;	NULL
-45	NULL
,	NULL
16	NULL
;	NULL
-41	NULL
,	NULL
10.3	NULL
;	NULL
and	NULL
-37	NULL
,	NULL
12.3	NULL
.	NULL

5240	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
A	NULL
B	NULL
Probe	NULL
|	NULL
--	NULL
-85	NULL
to	NULL
-59nt	NULL
--	NULL
Cell	NULL
Type	NULL
|	NULL
--	NULL
Ar§	NULL
_	NULL
--	NULL
A20	NULL
(	NULL
B	NULL
)	NULL
--	NULL
NE	NULL
-	NULL
pArSq	NULL
-	NULL
A207	NULL
ie	NULL
.	NULL

-	NULL
%	NULL
``	NULL
e__	NULL
__	NULL
re	NULL
UN	NULL
-	NULL
CsAUN	NULL
-	NULL
CsA	NULL
-	NULL
UN	NULL
-	NULL
CsA	NULL
UN	NULL
-	NULL
CsA	NULL
u	NULL
sow	NULL
wn	NULL
.	NULL

wen	NULL
we	NULL
an	NULL
ag	NULL
be	NULL
-	NULL
-	NULL
Woo	NULL
1s	NULL
Whitty	NULL
.	NULL

»	NULL
>	NULL
102	NULL
3	NULL
4	NULL
506	NULL
7	NULL
80	NULL
9	NULL
10	NULL
11	NULL
12	NULL
-85	NULL
59	NULL
-85	NULL
to	NULL
-59	NULL
-	NULL
CAAGGAAGTTTTCCGCTGGTTGAATGA	NULL
-85	NULL
to	NULL
-59M	NULL
CACT	NULL
imbue	NULL
FIG	NULL
.	NULL

9	NULL
.	NULL

Binding	NULL
of	NULL
complexes	NULL
in	NULL
Ar-5	NULL
T-cell	NULL
and	NULL
A20	NULL
B-cell	NULL
nuclear	NULL
extracts	NULL
to	NULL
the	NULL
-85	NULL
to	NULL
-59	NULL
oligonucleotide	NULL
probe	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Binding	NULL
of	NULL
factors	NULL
to	NULL
WT	NULL
and	NULL
mutated	NULL
(	NULL
Mut	NULL
)	NULL
-85	NULL
to	NULL
-59	NULL
oligonucleotides	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
A20	NULL
and	NULL
Ar-5	NULL
cells	NULL
.	NULL

An	NULL
inducible	NULL
,	NULL
CsA-sensitive	NULL
complex	NULL
binds	NULL
to	NULL
the	NULL
-85	NULL
to	NULL
-59	NULL
nt	NULL
probe	NULL
(	NULL
WT	NULL
)	NULL
in	NULL
nuclear	NULL
extracts	NULL
derived	NULL
from	NULL
either	NULL
Ar-5	NULL
cells	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
(	NULL
+	NULL
)	NULL
or	NULL
A20	NULL
cells	NULL
stimulated	NULL
with	NULL
P+I	NULL
(	NULL
+	NULL
)	NULL
.	NULL

A	NULL
mutation	NULL
in	NULL
the	NULL
core	NULL
NFAT-binding	NULL
motif	NULL
of	NULL
the	NULL
-85	NULL
to	NULL
-59	NULL
probe	NULL
(	NULL
Mut	NULL
)	NULL
abrogates	NULL
binding	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
.	NULL

Ar-5	NULL
T	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
A20	NULL
B	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
P+1I	NULL
for	NULL
30	NULL
min	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
CsA	NULL
.	NULL

The	NULL
amounts	NULL
of	NULL
mutant	NULL
probe	NULL
in	NULL
lanes	NULL
4	NULL
to	NULL
6	NULL
and	NULL
10	NULL
to	NULL
12	NULL
are	NULL
less	NULL
than	NULL
the	NULL
amounts	NULL
of	NULL
WT	NULL
probe	NULL
in	NULL
lanes	NULL
1	NULL
to	NULL
3	NULL
and	NULL
7	NULL
to	NULL
9	NULL
.	NULL

However	NULL
,	NULL
even	NULL
on	NULL
a	NULL
much	NULL
darker	NULL
exposure	NULL
,	NULL
no	NULL
binding	NULL
complexes	NULL
in	NULL
either	NULL
cell	NULL
type	NULL
that	NULL
associate	NULL
with	NULL
the	NULL
mutant	NULL
probe	NULL
are	NULL
observed	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Reactivity	NULL
of	NULL
an	NULL
NFATp	NULL
antibody	NULL
(	NULL
aNFATp	NULL
)	NULL
with	NULL
the	NULL
-85	NULL
to	NULL
-59	NULL
nt	NULL
probe	NULL
in	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
Ar-5	NULL
cells	NULL
or	NULL
A20	NULL
cells	NULL
.	NULL

Ar-5	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
ionomycin	NULL
for	NULL
30	NULL
min	NULL
,	NULL
and	NULL
A20	NULL
cells	NULL
were	NULL
stimulated	NULL
with	NULL
P+1	NULL
for	NULL
30	NULL
min	NULL
.	NULL

The	NULL
EMSA	NULL
was	NULL
performed	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
the	NULL
anti-NFATp	NULL
antibody	NULL
as	NULL
described	NULL
in	NULL
Materials	NULL
and	NULL
Methods	NULL
.	NULL

that	NULL
NFATp-binding	NULL
activity	NULL
is	NULL
more	NULL
abundant	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
than	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

Finally	NULL
,	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
composite	NULL
k3	NULL
(	NULL
L	NULL
)	NULL
element	NULL
(	NULL
which	NULL
contains	NULL
only	NULL
a	NULL
single	NULL
copy	NULL
of	NULL
the	NULL
NFAT	NULL
binding	NULL
site	NULL
)	NULL
,	NULL
similar	NULL
to	NULL
the	NULL
single	NULL
copy	NULL
in	NULL
the	NULL
intact	NULL
promoter	NULL
,	NULL
is	NULL
not	NULL
inducible	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
but	NULL
is	NULL
induced	NULL
approximately	NULL
10-fold	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

Only	NULL
when	NULL
the	NULL
composite	NULL
site	NULL
is	NULL
oli-gomerized	NULL
can	NULL
it	NULL
confer	NULL
inducibility	NULL
on	NULL
a	NULL
synthetic	NULL
promoter	NULL
in	NULL
A20	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
,	NULL
these	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
possibility	NULL
that	NULL
a	NULL
threshold	NULL
level	NULL
of	NULL
NFATp	NULL
is	NULL
required	NULL
for	NULL
DNA	NULL
binding	NULL
to	NULL
certain	NULL
sites	NULL
.	NULL

Our	NULL
footprinting	NULL
analysis	NULL
showed	NULL
that	NULL
the	NULL
-76	NULL
site	NULL
bound	NULL
NFATp	NULL
at	NULL
the	NULL
lowest	NULL
concentrations	NULL
.	NULL

Thus	NULL
,	NULL
although	NULL
the	NULL
NFATp	NULL
concentration	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
is	NULL
sufficient	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
-76	NULL
site	NULL
,	NULL
the	NULL
concentration	NULL
of	NULL
NFATp	NULL
required	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
x3	NULL
site	NULL
is	NULL
apparently	NULL
not	NULL
reached	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
as	NULL
it	NULL
is	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
observations	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
idea	NULL
that	NULL
the	NULL
lower	NULL
abundance	NULL
of	NULL
NFATp	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
combined	NULL
with	NULL
the	NULL
x3	NULL
element	NULL
's	NULL
lower	NULL
affinity	NULL
for	NULL
NFAT	NULL
accounts	NULL
for	NULL
the	NULL
cell-type-specific	NULL
association	NULL
of	NULL
NFAT	NULL
p	NULL
with	NULL
x3	NULL
in	NULL
the	NULL
two	NULL
cell	NULL
types	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
CRE/x3	NULL
site	NULL
functions	NULL
as	NULL
a	NULL
composite	NULL
promoter	NULL
element	NULL
binding	NULL
factors	NULL
from	NULL
different	NULL
transcription	NULL
factor	NULL
families	NULL
,	NULL
exemplified	NULL
by	NULL
NFATp	NULL
and	NULL
ATF-2-Jun	NULL
,	NULL
whereas	NULL
in	NULL
A20	NULL
B	NULL
cells	NULL
the	NULL
site	NULL
functions	NULL
as	NULL
a	NULL
simple	NULL
site	NULL
and	NULL
binds	NULL
only	NULL
to	NULL
one	NULL
class	NULL
of	NULL
proteins	NULL
,	NULL
represented	NULL
by	NULL
ATF-2-Jun	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
B-cell	NULL
line	NULL
A20	NULL
serves	NULL
as	NULL
a	NULL
prototype	NULL
of	NULL
cells	NULL
in	NULL
which	NULL
there	NULL
are	NULL
relatively	NULL
lower	NULL
levels	NULL
of	NULL
NFAT	NULL
proteins	NULL
and	NULL
in	NULL
which	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
is	NULL
induced	NULL
.	NULL

Our	NULL
results	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
is	NULL
regulated	NULL
in	NULL
a	NULL
specific	NULL
manner	NULL
in	NULL
cells	NULL
that	NULL
is	NULL
concordant	NULL
with	NULL
CELL-TYPE-SPECIFIC	NULL
REGULATION	NULL
OF	NULL
THE	NULL
HUMAN	NULL
TNF-	NULL
«	NULL
GENE	NULL
5241	NULL
their	NULL
levels	NULL
of	NULL
NFAT	NULL
proteins	NULL
.	NULL

In	NULL
future	NULL
studies	NULL
,	NULL
it	NULL
will	NULL
be	NULL
important	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
results	NULL
obtained	NULL
for	NULL
A20	NULL
cells	NULL
can	NULL
be	NULL
generalized	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
in	NULL
other	NULL
B	NULL
cells	NULL
or	NULL
whether	NULL
our	NULL
observations	NULL
reflect	NULL
a	NULL
cell-type-specific	NULL
phenomenon	NULL
that	NULL
may	NULL
occur	NULL
in	NULL
cell	NULL
types	NULL
from	NULL
a	NULL
variety	NULL
of	NULL
tissues	NULL
and	NULL
lineages	NULL
.	NULL

NFATp	NULL
is	NULL
a	NULL
member	NULL
of	NULL
the	NULL
NFAT	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
,	NULL
which	NULL
includes	NULL
NFATp	NULL
,	NULL
NFAT	NULL
,	NULL
NFAT-3	NULL
,	NULL
and	NULL
NFAT-4	NULL
(	NULL
11	NULL
,	NULL
16	NULL
,	NULL
19	NULL
,	NULL
22	NULL
)	NULL
.	NULL

There	NULL
is	NULL
evidence	NULL
that	NULL
both	NULL
NFATp	NULL
and	NULL
NFATc	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
transcriptional	NULL
regulation	NULL
of	NULL
the	NULL
IL-2	NULL
gene	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
19	NULL
,	NULL
22	NULL
)	NULL
,	NULL
and	NULL
the	NULL
binding	NULL
specificities	NULL
of	NULL
these	NULL
two	NULL
proteins	NULL
appear	NULL
to	NULL
be	NULL
identical	NULL
(	NULL
11	NULL
,	NULL
26	NULL
)	NULL
.	NULL

We	NULL
note	NULL
that	NULL
NFATe	NULL
is	NULL
also	NULL
present	NULL
in	NULL
both	NULL
A20	NULL
B	NULL
cells	NULL
and	NULL
Ar-5	NULL
T	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Antibodies	NULL
to	NULL
NFATe	NULL
specifically	NULL
recognize	NULL
the	NULL
x3	NULL
NFAT	NULL
complexes	NULL
in	NULL
Ar-5	NULL
T-cell	NULL
nuclear	NULL
extracts	NULL
but	NULL
do	NULL
not	NULL
recognize	NULL
the	NULL
x3-binding	NULL
complex	NULL
in	NULL
A20	NULL
nuclear	NULL
extracts	NULL
.	NULL

Moreover	NULL
,	NULL
as	NULL
expected	NULL
,	NULL
the	NULL
NFATc	NULL
antibodies	NULL
recognize	NULL
the	NULL
complexes	NULL
binding	NULL
to	NULL
the	NULL
-76	NULL
site	NULL
in	NULL
both	NULL
cell	NULL
types	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

These	NULL
results	NULL
lend	NULL
further	NULL
support	NULL
to	NULL
a	NULL
cell-type-specific	NULL
model	NULL
of	NULL
k3-NFAT	NULL
binding	NULL
and	NULL
are	NULL
consistent	NULL
with	NULL
the	NULL
notion	NULL
that	NULL
the	NULL
higher	NULL
concentrations	NULL
of	NULL
NFATp	NULL
and	NULL
NFATc	NULL
in	NULL
Ar-5	NULL
cells	NULL
achieve	NULL
a	NULL
certain	NULL
threshold	NULL
level	NULL
required	NULL
for	NULL
binding	NULL
to	NULL
the	NULL
«	NULL
3	NULL
site	NULL
.	NULL

Of	NULL
interest	NULL
,	NULL
NFATp	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
all	NULL
four	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
NFAT	NULL
-binding	NULL
sites	NULL
without	NULL
a	NULL
bZIP	NULL
protein	NULL
partner	NULL
.	NULL

This	NULL
is	NULL
in	NULL
contrast	NULL
to	NULL
findings	NULL
for	NULL
other	NULL
cytokine	NULL
promoters	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
fac-tor	NULL
,	NULL
and	NULL
IL-4	NULL
,	NULL
in	NULL
which	NULL
at	NULL
least	NULL
some	NULL
of	NULL
the	NULL
NFAT	NULL
-binding	NULL
sites	NULL
do	NULL
require	NULL
pairing	NULL
with	NULL
an	NULL
AP-1-like	NULL
partner	NULL
and	NULL
in	NULL
which	NULL
cooperative	NULL
binding	NULL
interactions	NULL
between	NULL
the	NULL
two	NULL
groups	NULL
of	NULL
proteins	NULL
can	NULL
be	NULL
demonstrated	NULL
(	NULL
reviewed	NULL
in	NULL
reference	NULL
21	NULL
)	NULL
.	NULL

In	NULL
the	NULL
IL-2	NULL
promoter	NULL
,	NULL
for	NULL
example	NULL
,	NULL
four	NULL
of	NULL
the	NULL
five	NULL
NFAT	NULL
-binding	NULL
sites	NULL
bind	NULL
NFAT	NULL
in	NULL
association	NULL
with	NULL
AP-1	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
it	NULL
is	NULL
interesting	NULL
that	NULL
the	NULL
TNF-a	NULL
CRE	NULL
site	NULL
in	NULL
particular	NULL
is	NULL
capable	NULL
of	NULL
binding	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
recombinant	NULL
AP-1	NULL
family	NULL
proteins	NULL
,	NULL
including	NULL
Fos	NULL
,	NULL
Jun	NULL
,	NULL
and	NULL
ATF-2	NULL
.	NULL

However	NULL
,	NULL
the	NULL
x3	NULL
site	NULL
does	NULL
not	NULL
require	NULL
a	NULL
bZIP	NULL
protein	NULL
partner	NULL
to	NULL
bind	NULL
to	NULL
NFATp	NULL
.	NULL

Instead	NULL
,	NULL
the	NULL
site	NULL
appears	NULL
to	NULL
act	NULL
as	NULL
a	NULL
junction	NULL
point	NULL
(	NULL
as	NULL
originally	NULL
defined	NULL
by	NULL
Miner	NULL
and	NULL
Yamamoto	NULL
in	NULL
1992	NULL
[	NULL
20	NULL
]	NULL
)	NULL
for	NULL
the	NULL
interaction	NULL
of	NULL
two	NULL
different	NULL
transcription	NULL
factor	NULL
families	NULL
,	NULL
AP-1	NULL
and	NULL
NFAT	NULL
proteins	NULL
.	NULL

This	NULL
view	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
footprinting	NULL
analysis	NULL
,	NULL
which	NULL
shows	NULL
that	NULL
the	NULL
sequences	NULL
spanning	NULL
from	NULL
-121	NULL
to	NULL
-67	NULL
form	NULL
a	NULL
large	NULL
footprint	NULL
with	NULL
NFATp	NULL
and	NULL
ATF-2-Jun	NULL
interdigitating	NULL
at	NULL
the	NULL
k3/CRE	NULL
site	NULL
(	NULL
Fig	NULL
.	NULL

11	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
«	NULL
k3/CRE	NULL
composite	NULL
site	NULL
is	NULL
capable	NULL
of	NULL
producing	NULL
novel	NULL
regulatory	NULL
consequences	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
,	NULL
perhaps	NULL
through	NULL
protein-protein	NULL
interactions	NULL
between	NULL
ATF-2-Jun	NULL
and	NULL
NFATp	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
supported	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
just	NULL
one	NULL
copy	NULL
of	NULL
the	NULL
intact	NULL
CRE/k3	NULL
site	NULL
is	NULL
a	NULL
potent	NULL
calcium-inducible	NULL
promoter	NULL
element	NULL
when	NULL
linked	NULL
to	NULL
a	NULL
truncated	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
whereas	NULL
multiple	NULL
copies	NULL
of	NULL
the	NULL
x3	NULL
site	NULL
alone	NULL
are	NULL
required	NULL
for	NULL
inducible	NULL
activity	NULL
(	NULL
8	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Our	NULL
quantitative	NULL
DNase	NULL
analysis	NULL
demonstrated	NULL
a	NULL
lack	NULL
of	NULL
cooperative	NULL
binding	NULL
between	NULL
ATF-2-Jun	NULL
and	NULL
NFATp	NULL
,	NULL
as	NULL
did	NULL
previous	NULL
EMSA	NULL
analyses	NULL
(	NULL
29	NULL
)	NULL
.	NULL

Perhaps	NULL
the	NULL
functional	NULL
synergy	NULL
of	NULL
the	NULL
CRE	NULL
and	NULL
x3	NULL
in	NULL
T	NULL
cells	NULL
is	NULL
a	NULL
consequence	NULL
of	NULL
the	NULL
interaction	NULL
of	NULL
the	NULL
proteins	NULL
that	NULL
bind	NULL
to	NULL
the	NULL
sites	NULL
with	NULL
some	NULL
other	NULL
factor	NULL
or	NULL
constituent	NULL
of	NULL
the	NULL
transcription	NULL
apparatus	NULL
and	NULL
not	NULL
with	NULL
each	NULL
other	NULL
.	NULL

Such	NULL
interactions	NULL
have	NULL
been	NULL
previously	NULL
suggested	NULL
in	NULL
other	NULL
cases	NULL
of	NULL
eukaryotic	NULL
transcripional	NULL
activators	NULL
that	NULL
do	NULL
not	NULL
cooperatively	NULL
bind	NULL
but	NULL
do	NULL
cooperatively	NULL
activate	NULL
transcription	NULL
(	NULL
2	NULL
,	NULL
15	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
other	NULL
genes	NULL
in	NULL
which	NULL
NFAT	NULL
proteins	NULL
play	NULL
a	NULL
role	NULL
,	NULL
TNF-	NULL
«	NULL
transcription	NULL
in	NULL
B	NULL
or	NULL
T	NULL
cells	NULL
does	NULL
not	NULL
require	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
and	NULL
calcium	NULL
flux	NULL
alone	NULL
is	NULL
sufficient	NULL
for	NULL
the	NULL
gene	NULL
's	NULL
rapid	NULL
induction	NULL
(	NULL
7	NULL
,	NULL
8	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

We	NULL
have	NULL
shown	NULL
here	NULL
that	NULL
all	NULL
four	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
NFAT	NULL
-binding	NULL
sites	NULL
are	NULL
'LTt	NULL
01	NULL
7T	NULL
pue	NULL
4	NULL
,	NULL
01	NULL
|	NULL
souey	NULL
0	NULL
,	NULL
(	NULL
Fu	NULL
991	NULL
10	NULL
``	NULL
pg	NULL
'	NULL
g	NULL
'L9'T	NULL
5p	NULL
)	NULL
syunoure	NULL
Fursearout	NULL
ur	NULL
poppe	NULL
sem	NULL
d	NULL
EVAN	NULL
't	NULL
01	NULL
TJ	NULL
sous	NULL
]	NULL
ut	NULL
Su	NULL
pps	NULL
12	NULL
poppe	NULL
pue	NULL
|J	NULL
01	NULL
g	NULL
sous	NULL
;	NULL
ut	NULL
(	NULL
Fu	NULL
qos	NULL
pus	NULL
``	NULL
OZ	NULL
'	NULL
g	NULL
'	NULL
g	NULL
)	NULL
stunowe	NULL
Sursearout	NULL
uf	NULL
poppe	NULL
sem	NULL
unf-g-4	NULL
[	NULL
V	NULL
'surjoid	NULL
pajeotput	NULL
94	NULL
}	NULL
yjIM	NULL
pajeqnout	NULL
pue	NULL
pues	NULL
Surpoouou	NULL
ay	NULL
}	NULL
12	NULL
(	NULL
tudo	NULL
puo	NULL
sex	NULL
agord	NULL
941	NULL
,	NULL
e	NULL
se	NULL
1sjoword	NULL
©-4NJ	NULL
,	NULL
(	NULL
4,5	NULL
)	NULL
poreinw	NULL
aq	NULL
}	NULL
Sursn	NULL
Aesse	NULL
Supundj007	NULL
1	NULL
aseng	NULL
saneinuen	NULL
(	NULL
)	NULL
(	NULL
g	NULL
)	NULL
'	NULL
(	NULL
gz	NULL
pue	NULL
umogs	NULL
jou	NULL
sep	NULL
)	NULL
[	NULL
wor	NULL
]	NULL
``	NULL
ols	NULL
g	NULL
>	NULL
-IN	NULL
eoq	NULL
aq	NULL
;	NULL
papsio1d	NULL
aures	NULL
asay	NULL
}	NULL
jeg	NULL
}	NULL
9100	NULL
3M	NULL
'pZ	NULL
01	NULL
JZ	NULL
sour	NULL
]	NULL
pue	NULL
qj	NULL
01	NULL
,	NULL
sour	NULL
;	NULL
01	NULL
(	NULL
3x	NULL
)	NULL
1	NULL
pue	NULL
Su	NULL
pez	NULL
pue	NULL
'pg	NULL
(	NULL
01	NULL
)	NULL
s1unouwme	NULL
ut	NULL
pappe	NULL
sem	NULL
god-o5d	NULL
941	NULL
)	NULL
g	NULL
>	NULL
-4N	NULL
``	NULL
bp	NULL
01	NULL
Op	NULL
PUE	NULL
'	NULL
p€	NULL
01	NULL
0€	NULL
'OZ	NULL
01	NULL
9T	NULL
'	NULL
o	NULL
01	NULL
7	NULL
sour	NULL
;	NULL
03	NULL
(	NULL
Fu	NULL
005	NULL
pue	NULL
'szt	NULL
'ge	NULL
'	NULL
*z	NULL
)	NULL
s1unowe	NULL
Sursearut	NULL
ut	NULL
poppe	NULL
sem	NULL
oy	NULL
}	NULL
4q	NULL
poreotpur	NULL
se	NULL
'gp	NULL
01	NULL
5p	NULL
pue	NULL
'gg	NULL
01	NULL
5g	NULL
01	NULL
TZ	NULL
'01	NULL
01	NULL
£	NULL
ut	NULL
(	NULL
Fu	NULL
pps	NULL
puse	NULL
'	NULL
g'¢	NULL
)	NULL
Stunowe	NULL
Sursearout	NULL
ut	NULL
poppe	NULL
sem	NULL
unp-g-4	NULL
LV	NULL
'sursjord	NULL
aq	NULL
}	NULL
iM	NULL
pojeqnout	NULL
pue	NULL
pues	NULL
Surposuou	NULL
ayy	NULL
1e	NULL
(	NULL
ado	NULL
potoqe|	NULL
pus	NULL
s10m	NULL
pyyg	NULL
10	NULL
'py,5	NULL
(	NULL
Arg	NULL
,	NULL
oy	NULL
)	NULL
Surkures	NULL
ssouanbes	NULL
10	NULL
(	NULL
[	NULL
M	NULL
)	NULL
01	NULL
(	NULL
0Z-	NULL
wop	NULL
Suruaeds	NULL
ssouanbag	NULL
'sareidino	NULL
}	NULL
se	NULL
*-4NI	NULL
poreinu	NULL
pue	NULL
[	NULL
M	NULL
Sursn	NULL
esse	NULL
Supurmdjoo	NULL
;	NULL
1	NULL
aseng	NULL
(	NULL
y	NULL
)	NULL
'rmoword	NULL
f	NULL
,	NULL
ay	NULL
}	NULL
03	NULL
purq	NULL
jou	NULL
op	NULL
sursjord	NULL
gx-qgp	NULL
'ogta	NULL
ut	NULL
Surparq	NULL
unp-z-4	NULL
[	NULL
y	NULL
pue	NULL
dipyygp	NULL
uo	NULL
xsjowoid	NULL
©-4NJ	NULL
,	NULL
JO	NULL
'Of	NULL
(	NULL
ODM	NULL
ALV	NULL
om	NULL
mmm	NULL
:	NULL
_	NULL
eate	NULL
~	NULL
wNNru	NULL
|	NULL
<	NULL
~	NULL
u	NULL
...	NULL
”	NULL
5	NULL
-S	NULL
aa	NULL
«	NULL
1	NULL
-s9r-	NULL
4k	NULL
@	NULL
:	NULL
*	NULL
gg	NULL
»	NULL
f	NULL
#	NULL
I	NULL
BEE	NULL
sss	NULL
--	NULL
..	NULL
-wte-egze	NULL
«	NULL
~	NULL
-	NULL
wann	NULL
=-smt	NULL
#	NULL
-	NULL
~	NULL
#	NULL
-~	NULL
Maw-In	NULL
”	NULL
-PP1	NULL
=3~	NULL
sues	NULL
=	NULL
se	NULL
=	NULL
it	NULL
te	NULL
it	NULL
se	NULL
'	NULL
ﬂ.r.w	NULL
1	NULL
T	NULL
k-	NULL
sess-	NULL
:	NULL
ss	NULL
;	NULL
y/2	NULL
%	NULL
i	NULL
%	NULL
L1	NULL
T3	NULL
it	NULL
Cpp	NULL
®	NULL
UBC	NULL
-z	NULL
cue	NULL
di	NULL
ly	NULL
aus	NULL
.-	NULL
.	NULL

n	NULL
Gp	NULL
an	NULL
..	NULL
<	NULL
cn	NULL
dn	NULL
dolce	NULL
w	NULL
an	NULL
o	NULL
t	NULL
tte	NULL
-	NULL
el	NULL
#	NULL
a	NULL
l.|4	NULL
llim	NULL
z	NULL
~	NULL
|	NULL
-4	NULL
@	NULL
=	NULL
&	NULL
W	NULL
-	NULL
POL	NULL
|	NULL
Thi	NULL
-	NULL
-z6	NULL
a	NULL
m	NULL
lg-le-	NULL
bo	NULL
~	NULL
Oh	NULL
4	NULL
..	NULL
,	NULL
_	NULL
.	NULL

‘	NULL
l.i	NULL
‘	NULL
n	NULL
.	NULL

T	NULL
e	NULL
T	NULL
‘	NULL
l	NULL
outfit	NULL
.	NULL

e	NULL
i	NULL
}	NULL
#	NULL
!	NULL
}	NULL

|	NULL
|	NULL
I	NULL
[	NULL
&	NULL
I	NULL
6	NULL
ne	NULL
(	NULL
R	NULL
C	NULL
ae	NULL
Ob	NULL
LF	NULL
Ob	NULL
Ship	NULL
98	NULL
EE	NULL
be	NULL
EERE	NULL
LE	NULL
OR	NULL
62	NULL
BZ	NULL
12	NULL
92	NULL
9292	NULL
C2	NULL
22	NULL
L202	NULL
Bli	NULL
aL	NULL
9191	NULL
.	NULL

PLELZLLL	NULL
OL	NULL
6	NULL
8	NULL
2	NULL
9	NULL
§	NULL
pog	NULL
Z	NULL
LL	NULL
9LSI	NULL
LEL	NULL
ZLLLOL	NULL
6	NULL
g	NULL
1	NULL
9	NULL
s	NULL
¢	NULL
g	NULL
z	NULL
1	NULL
wo	NULL
(	NULL
C	NULL
--	NULL
[	NULL
--	NULL
-	NULL
LL	NULL
--	NULL
--	NULL
*	NULL
-	NULL
C	NULL
--	NULL
--	NULL
-	NULL
dIWN	NULL
a	NULL
s	NULL
-	NULL
_	NULL
unreqly	NULL
z-	NULL
-	NULL
___	NULL
C	NULL
-	NULL
(	NULL
a-	NULL
*~	NULL
C	NULL
--	NULL
--	NULL
dIWN	NULL
dI¥IN	NULL
(	NULL
~3_	NULL
c_	NULL
.	NULL

--	NULL
~	NULL
--	NULL
*	NULL
-	NULL
unf-41Y	NULL
4	NULL
WS	NULL
!	NULL

aqoid	NULL
8qoid	NULL
w	NULL
e	NULL
__	NULL
i	NULL
Ww9L-	NULL
%	NULL
LM	NULL
'	NULL
agoid	NULL
'	NULL
g	NULL
'	NULL
V	NULL
5242	NULL
Vou	NULL
.	NULL

16	NULL
,	NULL
1996	NULL
CELL-TYPE-SPECIFIC	NULL
REGULATION	NULL
OF	NULL
THE	NULL
HUMAN	NULL
TNF-	NULL
«	NULL
GENE	NULL
5243	NULL
A	NULL
NFATp	NULL
:	NULL
*	NULL
00	NULL
190	NULL
180	NULL
170	NULL
TC	NULL
.	NULL

§0	NULL
aao	NULL
Arsettetetétccccaacttrecaaatcoteococof	NULL
SAoachoarcet	NULL
_	NULL
NFAT	NULL
-149	NULL
yet	NULL
%	NULL
1/4513	NULL
i	NULL
“	NULL
\	NULL
“	NULL
/2\	NULL
*	NULL
etn	NULL
.	NULL

~	NULL
(	NULL
Neate	NULL
)	NULL
(	NULL
&	NULL
~	NULL
?	NULL

pasion	NULL
Aa	NULL
La	NULL
rarer	NULL
ad	NULL
ag	NULL
.	NULL

|	NULL
.	NULL

sorésscceac	NULL
ﬁééﬁ	NULL
mTeAATGATTC	NULL
A	NULL
ACIACCGEI	NULL
EE	NULL
I	NULL
ua	NULL
u	NULL
-	NULL
=	NULL
``	NULL
1TGAATGATT	NULL
NFAT	NULL
-117	NULL
ATF-2/Jun-CRE	NULL
NFATx3	NULL
NFAT	NULL
-76	NULL
uf/	NULL
--	NULL
-\	NULL
‘	NULL
.|	NULL
isp	NULL
]	NULL
-+	NULL
Ce	NULL
40	NULL
30	NULL
ao	NULL
£1	NULL
Ad	NULL
TTTCCCECGCCCTCCTCTCGCCCCAGGGACATATAAAGGCAGTTGTTGGCACACCCA	NULL
B.	NULL
A20	NULL
B	NULL
Celis	NULL
NFAT	NULL
-149	NULL
Ar-5	NULL
T	NULL
Cells	NULL
_	NULL
ffiraty	NULL
NFAT	NULL
-117	NULL
NFATr3	NULL
-	NULL
NFAT	NULL
-76	NULL
FIG	NULL
.	NULL

11	NULL
.	NULL

Model	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
promoter	NULL
.	NULL

(	NULL
A	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
results	NULL
of	NULL
the	NULL
footprinting	NULL
analysis	NULL
with	NULL
recombinant	NULL
NFATp	NULL
and	NULL
ATF-2-Jun	NULL
proteins	NULL
.	NULL

NFATp	NULL
associates	NULL
with	NULL
four	NULL
different	NULL
regions	NULL
contained	NULL
within	NULL
200	NULL
nt	NULL
upstream	NULL
of	NULL
the	NULL
TNF-	NULL
«	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

ATF-2	NULL
and	NULL
Jun	NULL
proteins	NULL
bind	NULL
to	NULL
a	NULL
CRE	NULL
consensus	NULL
sequence	NULL
.	NULL

In	NULL
other	NULL
studies	NULL
,	NULL
we	NULL
have	NULL
demonstrated	NULL
that	NULL
SP-1	NULL
binds	NULL
to	NULL
an	NULL
SP-1	NULL
consensus	NULL
sequence	NULL
located	NULL
at	NULL
-52	NULL
to	NULL
-45	NULL
nt	NULL
(	NULL
10a	NULL
)	NULL
.	NULL

The	NULL
start	NULL
site	NULL
of	NULL
transcription	NULL
is	NULL
at	NULL
+1	NULL
.	NULL

(	NULL
B	NULL
)	NULL
Summary	NULL
of	NULL
the	NULL
cell-type-specific	NULL
association	NULL
of	NULL
NFATp	NULL
with	NULL
the	NULL
TNF-	NULL
«	NULL
promoter	NULL
in	NULL
Ar-5	NULL
T	NULL
cells	NULL
and	NULL
A20	NULL
B	NULL
cells	NULL
.	NULL

capable	NULL
of	NULL
binding	NULL
NFATp	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
AP-1	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
regulation	NULL
of	NULL
TNF-	NULL
«	NULL
can	NULL
be	NULL
distinguished	NULL
from	NULL
,	NULL
for	NULL
example	NULL
,	NULL
the	NULL
pattern	NULL
of	NULL
expression	NULL
of	NULL
IL-2	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
which	NULL
occurs	NULL
with	NULL
slower	NULL
kinetics	NULL
(	NULL
24	NULL
)	NULL
.	NULL

IL-2	NULL
gene	NULL
transcription	NULL
requires	NULL
the	NULL
cooperative	NULL
binding	NULL
of	NULL
Fos	NULL
and	NULL
Jun	NULL
proteins	NULL
with	NULL
NFAT	NULL
proteins	NULL
,	NULL
de	NULL
novo	NULL
protein	NULL
synthesis	NULL
,	NULL
and	NULL
protein	NULL
kinase	NULL
C	NULL
activity	NULL
in	NULL
addition	NULL
to	NULL
calcium	NULL
flux	NULL
(	NULL
24	NULL
)	NULL
.	NULL

The	NULL
analysis	NULL
presented	NULL
here	NULL
suggests	NULL
that	NULL
the	NULL
binding	NULL
affinity	NULL
of	NULL
a	NULL
promoter	NULL
for	NULL
a	NULL
particular	NULL
factor	NULL
may	NULL
be	NULL
sufficient	NULL
for	NULL
binding	NULL
in	NULL
certain	NULL
cell	NULL
types	NULL
and	NULL
too	NULL
low	NULL
for	NULL
effective	NULL
binding	NULL
in	NULL
another	NULL
.	NULL

In	NULL
this	NULL
manner	NULL
,	NULL
novel	NULL
patterns	NULL
of	NULL
gene	NULL
expression	NULL
can	NULL
result	NULL
from	NULL
the	NULL
cell-type-specific	NULL
interaction	NULL
of	NULL
a	NULL
promoter	NULL
with	NULL
a	NULL
particular	NULL
set	NULL
of	NULL
transcription	NULL
factors	NULL
.	NULL

Thus	NULL
,	NULL
a	NULL
promoter	NULL
may	NULL
accomplish	NULL
a	NULL
level	NULL
of	NULL
flexibility	NULL
in	NULL
its	NULL
response	NULL
to	NULL
a	NULL
particular	NULL
stimulus	NULL
,	NULL
depending	NULL
on	NULL
the	NULL
cell	NULL
type	NULL
in	NULL
which	NULL
it	NULL
functions	NULL
.	NULL

It	NULL
is	NULL
interesting	NULL
to	NULL
speculate	NULL
that	NULL
a	NULL
gene	NULL
such	NULL
as	NULL
the	NULL
TNF-	NULL
«	NULL
gene	NULL
,	NULL
which	NULL
is	NULL
expressed	NULL
in	NULL
multiple	NULL
cell	NULL
types	NULL
in	NULL
response	NULL
to	NULL
a	NULL
variety	NULL
of	NULL
inducers	NULL
,	NULL
may	NULL
have	NULL
evolved	NULL
this	NULL
level	NULL
of	NULL
flexibility	NULL
to	NULL
accomplish	NULL
novel	NULL
patterns	NULL
gene	NULL
regulation	NULL
.	NULL

Our	NULL
previous	NULL
studies	NULL
demonstrated	NULL
that	NULL
TNF-	NULL
«	NULL
is	NULL
an	NULL
autocrine	NULL
and	NULL
paracrine	NULL
B-cell	NULL
growth	NULL
factor	NULL
that	NULL
functions	NULL
much	NULL
the	NULL
way	NULL
IL-2	NULL
does	NULL
in	NULL
T	NULL
cells	NULL
(	NULL
1	NULL
)	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
understanding	NULL
of	NULL
TNF-	NULL
«	NULL
gene	NULL
regulation	NULL
in	NULL
B	NULL
cells	NULL
could	NULL
potentially	NULL
lead	NULL
to	NULL
novel	NULL
therapeutic	NULL
manipulations	NULL
that	NULL
interrupt	NULL
the	NULL
signaling	NULL
cascade	NULL
resulting	NULL
in	NULL
TNF-	NULL
«	NULL
gene	NULL
transcription	NULL
and	NULL
subsequent	NULL
protein	NULL
production	NULL
in	NULL
conditions	NULL
characterized	NULL
by	NULL
immuno-pathologic	NULL
proliferation	NULL
of	NULL
B	NULL
cells	NULL
.	NULL

A	NULL
detailed	NULL
understanding	NULL
of	NULL
TNF-a	NULL
«	NULL
gene	NULL
transcription	NULL
in	NULL
B	NULL
cells	NULL
also	NULL
offers	NULL
potential	NULL
novel	NULL
insights	NULL
regarding	NULL
the	NULL
role	NULL
of	NULL
the	NULL
shared	NULL
cytokine	NULL
transcription	NULL
factor	NULL
NFATp	NULL
in	NULL
immediate-early	NULL
gene	NULL
transcription	NULL
in	NULL
B	NULL
cells	NULL
.	NULL

ACKNOWLEDGMENTS	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
grants	NULL
from	NULL
the	NULL
NIH	NULL
(	NULL
CA42471	NULL
)	NULL
and	NULL
the	NULL
Arthritis	NULL
Foundation	NULL
to	NULL
A.E.G	NULL
.	NULL

and	NULL
by	NULL
a	NULL
March	NULL
of	NULL
Dimes	NULL
Basil	NULL
O'Connor	NULL
and	NULL
Irma	NULL
T.	NULL
Hirsch	NULL
]	NULL
Award	NULL
to	NULL
D.T	NULL
.	NULL

We	NULL
are	NULL
grateful	NULL
to	NULL
Jack	NULL
Strominger	NULL
for	NULL
research	NULL
support	NULL
in	NULL
the	NULL
early	NULL
phases	NULL
of	NULL
this	NULL
work	NULL
and	NULL
to	NULL
Tom	NULL
Maniatis	NULL
,	NULL
Anjana	NULL
Rao	NULL
,	NULL
and	NULL
Nancy	NULL
Rice	NULL
for	NULL
the	NULL
generous	NULL
provision	NULL
of	NULL
reagents	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Boussiotis	NULL
,	NULL
V.	NULL
A.	NULL
,	NULL
L.	NULL
M.	NULL
Nadler	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
A.	NULL
E.	NULL
Goldfeld	NULL
.	NULL

1994	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor-a	NULL
is	NULL
an	NULL
autocrine	NULL
growth	NULL
factor	NULL
for	NULL
normal	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
91:7007-7011	NULL
.	NULL

2	NULL
.	NULL

Carey	NULL
,	NULL
M.	NULL
,	NULL
Y.-S.	NULL
Lin	NULL
,	NULL
M.	NULL
R.	NULL
Green	NULL
,	NULL
and	NULL
M.	NULL
Ptashne	NULL
.	NULL

1990	NULL
.	NULL

A	NULL
mechanism	NULL
for	NULL
synergistic	NULL
activation	NULL
of	NULL
a	NULL
mammalian	NULL
gene	NULL
by	NULL
GALA	NULL
derivatives	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
345:361-364	NULL
.	NULL

3	NULL
.	NULL

Du	NULL
,	NULL
W.	NULL
,	NULL
D.	NULL
Thanos	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1993	NULL
.	NULL

Mechanisms	NULL
of	NULL
transcriptional	NULL
synergism	NULL
between	NULL
distinct	NULL
virus-inducible	NULL
elements	NULL
.	NULL

Cell	NULL
74:887-898	NULL
.	NULL

4	NULL
.	NULL

Economou	NULL
,	NULL
J.	NULL
S.	NULL
,	NULL
K.	NULL
Rhoades	NULL
,	NULL
R.	NULL
Essner	NULL
,	NULL
W.	NULL
H.	NULL
McBride	NULL
,	NULL
J.	NULL
C.	NULL
Gasson	NULL
,	NULL
and	NULL
D.	NULL
L.	NULL
Morton	NULL
.	NULL

1989	NULL
.	NULL

Genetic	NULL
analysis	NULL
of	NULL
the	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
e/cachectin	NULL
promoter	NULL
region	NULL
in	NULL
a	NULL
macrophage	NULL
cell	NULL
line	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

170	NULL
;	NULL
321-326	NULL
.	NULL

5	NULL
.	NULL

Goeddel	NULL
,	NULL
D.	NULL
V.	NULL
,	NULL
et	NULL
al	NULL
.	NULL

1986	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factors	NULL
:	NULL
gene	NULL
structure	NULL
and	NULL
biological	NULL
activities	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
Symp	NULL
.	NULL

Quant	NULL
.	NULL

Biol	NULL
.	NULL

60:597-609	NULL
.	NULL

6	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
C.	NULL
Doyle	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1990	NULL
.	NULL

Human	NULL
necrosis	NULL
factor-a	NULL
gene	NULL
regulation	NULL
by	NULL
virus	NULL
and	NULL
lipopolysaccharide	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
87:9769-9773	NULL
.	NULL

5244	NULL
7	NULL
.	NULL

10	NULL
.	NULL

TSAI	NULL
ET	NULL
AL	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
E.	NULL
K.	NULL
Flemington	NULL
,	NULL
V.	NULL
A	NULL
.	NULL

B	NULL
fotis	NULL
,	NULL
C.	NULL
M.	NULL
Theodose	NULL
,	NULL
R.	NULL
G.	NULL
Titus	NULL
,	NULL
I.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
S.	NULL
H.	NULL
Speck	NULL
.	NULL

1992	NULL
.	NULL

TNF-	NULL
«	NULL
gene	NULL
transcription	NULL
is	NULL
rapidly	NULL
induced	NULL
by	NULL
anti-immunoglobulin	NULL
and	NULL
blocked	NULL
by	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
in	NULL
human	NULL
B	NULL
cells	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
89:12198-12201.	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1993	NULL
.	NULL

The	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
gene	NULL
is	NULL
regulated	NULL
by	NULL
a	NULL
novel	NULL
cyclosporin-sensitive	NULL
promoter	NULL
element	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

178:1365-1379.	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
C.	NULL
Doyle	NULL
.	NULL

1991	NULL
.	NULL

Human	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
gene	NULL
regulation	NULL
in	NULL
phorbol	NULL
ester	NULL
stimulated	NULL
B	NULL
and	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

174:73-81	NULL
.	NULL

Goldfeld	NULL
,	NULL
A.	NULL
E.	NULL
,	NULL
E.	NULL
Tsai	NULL
,	NULL
R.	NULL
Kincaid	NULL
,	NULL
P.	NULL
J.	NULL
Belshaw	NULL
,	NULL
S.	NULL
L.	NULL
Schreiber	NULL
,	NULL
J.	NULL
L.	NULL
Strominger	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1994	NULL
.	NULL

Calcineurin	NULL
mediates	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
gene	NULL
induction	NULL
in	NULL
stimulated	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

180:763-768	NULL
.	NULL

102.Gordon	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
and	NULL
A.	NULL
E.	NULL
Goldfeld	NULL
.	NULL

Unpublished	NULL
data	NULL
.	NULL

11	NULL
.	NULL

12	NULL
.	NULL

13	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

Hoey	NULL
,	NULL
T.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
K.	NULL
Williamson	NULL
,	NULL
and	NULL
X.	NULL
Xu	NULL
.	NULL

1995	NULL
.	NULL

Isolation	NULL
of	NULL
two	NULL
new	NULL
members	NULL
of	NULL
the	NULL
NF-AT	NULL
gene	NULL
family	NULL
and	NULL
functional	NULL
characterization	NULL
of	NULL
the	NULL
NF-AT	NULL
proteins	NULL
.	NULL

Immunity	NULL
2461-472	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
P.	NULL
G.	NULL
Hogan	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1995	NULL
.	NULL

A	NULL
similar	NULL
DNA	NULL
binding	NULL
motif	NULL
in	NULL
NFAT	NULL
family	NULL
proteins	NULL
and	NULL
the	NULL
Rel	NULL
homology	NULL
region	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270:4138-4145	NULL
.	NULL

Jain	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
G.	NULL
McCaffrey	NULL
,	NULL
V.	NULL
E.	NULL
Valge-Archer	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
356:801-804	NULL
.	NULL

Leitman	NULL
,	NULL
D.	NULL
C.	NULL
,	NULL
R.	NULL
C.	NULL
J.	NULL
Ribeiro	NULL
,	NULL
E.	NULL
R.	NULL
Mackow	NULL
,	NULL
J.	NULL
D.	NULL
Baxter	NULL
,	NULL
and	NULL
B.	NULL
L.	NULL
West	NULL
.	NULL

1991	NULL
.	NULL

Identification	NULL
of	NULL
a	NULL
tumor	NULL
necrosis	NULL
factor-responsive	NULL
element	NULL
in	NULL
the	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266:9343-9346	NULL
.	NULL

Lin	NULL
,	NULL
Y.-S.	NULL
,	NULL
M.	NULL
Carey	NULL
,	NULL
M.	NULL
Ptashne	NULL
,	NULL
and	NULL
M.	NULL
R.	NULL
Green	NULL
.	NULL

1990	NULL
.	NULL

How	NULL
different	NULL
eukaryotic	NULL
transcriptional	NULL
activators	NULL
can	NULL
cooperate	NULL
promiscously	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
345:359-361	NULL
.	NULL

Masuda	NULL
,	NULL
E.	NULL
S.	NULL
,	NULL
Y.	NULL
Naito	NULL
,	NULL
H.	NULL
Tokumitsu	NULL
,	NULL
D.	NULL
Campbell	NULL
,	NULL
F.	NULL
Saito	NULL
,	NULL
C.	NULL
Hannum	NULL
,	NULL
K.-I	NULL
.	NULL

Arai	NULL
,	NULL
and	NULL
N.	NULL
Arai	NULL
.	NULL

1995	NULL
.	NULL

NFATsz	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
family	NULL
that	NULL
is	NULL
expressed	NULL
predominantly	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:2697-2706	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
A.	NULL
E.	NULL
Goldfeld	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1994	NULL
.	NULL

The	NULL
role	NULL
of	NULL
NFAT	NULL
in	NULL
TNFa	NULL
gene	NULL
regulation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:30445-30450	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
C.	NULL
Jamieson	NULL
,	NULL
R.	NULL
Sen	NULL
,	NULL
and	NULL
A.	NULL
Rao	NULL
.	NULL

1992	NULL
.	NULL

A	NULL
T	NULL
cell	NULL
nuclear	NULL
factor	NULL
resembling	NULL
NF-AT	NULL
binds	NULL
to	NULL
an	NULL
NF-kB	NULL
site	NULL
and	NULL
to	NULL
the	NULL
conserved	NULL
lymphokine	NULL
promoter	NULL
sequence	NULL
``	NULL
cytokine-1	NULL
.	NULL
``	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

267	NULL
:	NULL
1864-1871	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

Mor	NULL
.	NULL

CELL	NULL
.	NULL

BioL	NULL
.	NULL

McCaffrey	NULL
,	NULL
P.	NULL
G.	NULL
,	NULL
C.	NULL
Luo	NULL
,	NULL
T.	NULL
K.	NULL
Kerppola	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
T.	NULL
M.	NULL
Badalian	NULL
,	NULL
A.	NULL
M.	NULL
Ho	NULL
,	NULL
E.	NULL
Burgeon	NULL
,	NULL
W.	NULL
S.	NULL
Lane	NULL
,	NULL
J.	NULL
Lambert	NULL
,	NULL
T.	NULL
Curran	NULL
,	NULL
G.	NULL
Verdine	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
P.	NULL
G.	NULL
Hogan	NULL
.	NULL

1993	NULL
.	NULL

Isolation	NULL
of	NULL
the	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
262:750-754	NULL
.	NULL

Miner	NULL
,	NULL
J.	NULL
N.	NULL
,	NULL
and	NULL
K.	NULL
Yamamoto	NULL
.	NULL

1992	NULL
.	NULL

The	NULL
basic	NULL
region	NULL
of	NULL
AP-1	NULL
proteins	NULL
specifies	NULL
glucocorticoid	NULL
receptor	NULL
activity	NULL
at	NULL
a	NULL
composite	NULL
response	NULL
element	NULL
.	NULL

Genes	NULL
Dev	NULL
.	NULL

6:2491-2501	NULL
.	NULL

Nolan	NULL
,	NULL
G.	NULL
P.	NULL
1994	NULL
.	NULL

NF-AT-AP-1	NULL
and	NULL
Rel-bZIP	NULL
:	NULL
hybrid	NULL
vigor	NULL
and	NULL
binding	NULL
under	NULL
the	NULL
influence	NULL
.	NULL

Cell	NULL
77:795-798	NULL
.	NULL

Northorp	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
S.	NULL
N.	NULL
Ho	NULL
,	NULL
L.	NULL
Chen	NULL
,	NULL
D.	NULL
J.	NULL
Thomas	NULL
,	NULL
L.	NULL
A.	NULL
Timmerman	NULL
,	NULL
G.	NULL
P.	NULL
Nolan	NULL
,	NULL
A.	NULL
Admon	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1994	NULL
.	NULL

NFAT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Nature	NULL
(	NULL
London	NULL
)	NULL
269:497-502	NULL
.	NULL

Northorp	NULL
,	NULL
J.	NULL
P.	NULL
,	NULL
K.	NULL
S.	NULL
Ullman	NULL
,	NULL
and	NULL
G.	NULL
R.	NULL
Crabtree	NULL
.	NULL

1993	NULL
.	NULL

Characterization	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
NFAT	NULL
complex	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

269:497-502	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

1991	NULL
.	NULL

Signaling	NULL
mechanisms	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Crit	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

10:493-520.	NULL
.	NULL

Rao	NULL
,	NULL
A	NULL
.	NULL

1994	NULL
.	NULL

NF-ATp	NULL
:	NULL
a	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
the	NULL
co-ordinate	NULL
induction	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
15	NULL
(	NULL
6	NULL
)	NULL
:274-281	NULL
.	NULL

Rooney	NULL
,	NULL
J.	NULL
W.	NULL
,	NULL
Y.-L.	NULL
Sun	NULL
,	NULL
L.	NULL
H.	NULL
Glimcher	NULL
,	NULL
and	NULL
T.	NULL
Hoey	NULL
.	NULL

1995	NULL
.	NULL

Novel	NULL
NFAT	NULL
sites	NULL
that	NULL
mediate	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
in	NULL
response	NULL
to	NULL
T-cell	NULL
receptor	NULL
stimulation	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

15:6299-6310	NULL
.	NULL

Takashiba	NULL
,	NULL
S.	NULL
,	NULL
T.	NULL
E.	NULL
Van	NULL
Dyke	NULL
,	NULL
L.	NULL
Shapira	NULL
,	NULL
and	NULL
S.	NULL
Amar	NULL
.	NULL

1995	NULL
.	NULL

Lipopolysac-charide-inducible	NULL
and	NULL
salicylate-sensitive	NULL
nuclear	NULL
factor	NULL
(	NULL
s	NULL
)	NULL
on	NULL
human	NULL
tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
promoter	NULL
.	NULL

Infect	NULL
.	NULL

Immun	NULL
.	NULL

63:1529-15434	NULL
.	NULL

Thanos	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
T.	NULL
Maniatis	NULL
.	NULL

1995	NULL
.	NULL

Virus	NULL
induction	NULL
of	NULL
human	NULL
IFN	NULL
B	NULL
gene	NULL
expression	NULL
requires	NULL
the	NULL
assembly	NULL
of	NULL
an	NULL
enhanceosome	NULL
.	NULL

Cell	NULL
83:1091-1100	NULL
.	NULL

Tsai	NULL
,	NULL
E.	NULL
Y.	NULL
,	NULL
J.	NULL
Jain	NULL
,	NULL
P.	NULL
A.	NULL
Pesavento	NULL
,	NULL
A.	NULL
Rao	NULL
,	NULL
and	NULL
A.	NULL
E.	NULL
Goldfeld	NULL
.	NULL

1996	NULL
.	NULL

Tumor	NULL
necrosis	NULL
factor	NULL
alpha	NULL
gene	NULL
regulation	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
involves	NULL
ATF-2/Jun	NULL
and	NULL
NFATp	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16:459-467	NULL
.	NULL

Venkataraman	NULL
,	NULL
L.	NULL
,	NULL
D.	NULL
A.	NULL
Francis	NULL
,	NULL
Z.	NULL
Wang	NULL
,	NULL
J.	NULL
Liu	NULL
,	NULL
T.	NULL
L.	NULL
Rothstein	NULL
,	NULL
and	NULL
R.	NULL
Sen.	NULL
1994	NULL
.	NULL

Cyclosporin-A	NULL
sensitive	NULL
induction	NULL
of	NULL
NF-AT	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
1:189-196	NULL
.	NULL

Xie	NULL
,	NULL
H.	NULL
,	NULL
T.	NULL
C.	NULL
Childes	NULL
,	NULL
and	NULL
T.	NULL
L.	NULL
Rothstein	NULL
.	NULL

1993	NULL
.	NULL

Induction	NULL
of	NULL
CREB	NULL
activity	NULL
via	NULL
the	NULL
surface	NULL
Ig	NULL
receptor	NULL
of	NULL
B	NULL
cells	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151:880-889	NULL
.	NULL

Yaseen	NULL
,	NULL
N.	NULL
R.	NULL
,	NULL
A.	NULL
L.	NULL
Maizel	NULL
,	NULL
F.	NULL
Wang	NULL
,	NULL
and	NULL
S.	NULL
Sharma	NULL
.	NULL

1993	NULL
.	NULL

Comparative	NULL
analysis	NULL
of	NULL
NFAT	NULL
(	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
)	NULL
complex	NULL
in	NULL
human	NULL
T	NULL
and	NULL
B	NULL
lymphocytes	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268:14285-14293	NULL
.	NULL

